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Summary 
Proteins perform their role through the interactions they establish with other proteins and with 
small molecules, like ions or organic cofactors. The identification of these partners and of the 
mechanisms involved in their functional interactions can provide helpful insights into the 
molecular details of the protein annotation and for the development of new drugs. As many 
proteins lack of experimental structures and of annotated ligands, computational methods are 
required in order to predict these details and to guide the direction of experimental investigation.  
In this context, our main aim is to enhance protein functional annotation and to improve 
comparative models by inferring their potential binding cofactors. Moreover, we want to evaluate 
the current state-of-the-art methods for binding site prediction in order to understand their 
advantages and limitations for future developments. Additionally, we aimed to improve the 
assessment of binding site prediction methods by creating an automated system of continuous 
model evaluation. Finally, we created a new binding site descriptor for the de novo ligand and 
binding site prediction in protein models. 
The content of this thesis is organized as follows. Chapter 1 introduces protein structure, binding 
sites and experimental techniques for structure determination; moreover, we illustrate the current 
approaches to model protein structures and to predict their ligand binding sites. In chapter 2, we 
describe the assessment of the ligand binding site predictions within the 9th edition of the Critical 
Assessment of protein Structure Prediction (CASP) experiment, while in chapter 3 we discuss 
the latest developments in the 10th round. Within chapter 4 we illustrate the evolution of this 
assessment into the Continuous Automated Model EvaluatiOn (CAMEO) Ligand Binding 
category and we describe the homology predictor, which is used as reference for the 
comparison of the other methods registered to CAMEO. Chapter 5 presents the new SWISS-
MODEL server, which employs a base ligand modelling pipeline to place potential small 
molecules partners, inferred from the target‘s template, into the built models. Motivated by the 
performances of the previous method and by the results seen in the last CASP editions, in 
chapter 6 we present a new method to model ligands, especially ions and organic cofactors, into 
comparative models; this approach is based on the analysis of the similarities between a target 
and its homologous proteins. In chapter 7, we describe a novel descriptor for ligand binding 
sites, based on moment invariants and developed for the de novo prediction of ligands. Finally, 
in chapter 8 we draw the general conclusions of the work presented in this thesis.  
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1. Introduction 
Protein structure 
Many of the biological functions performed by living organisms are mediated by proteins, which 
can catalyse reactions (for instance, the production of metabolites), have a structural or 
mechanical role (like in the muscle fibre), propagate signals (e.g. the kinases), act as sensors of 
metabolites (as for neurotransmitter receptors), transport or store small molecules (e.g. oxygen 
in the haemoglobin). Proteins can be generally classified as "membrane proteins", when they act 
as receptors or as channels to allow the passage of charged molecules through a membrane, as 
"fibrous proteins", when they have a structural role, or as "globular proteins" in all the remaining 
cases. 
Primary and secondary structure 
A protein is a linear polymer composed of a chain of amino acids, called "residues", translated 
from a mRNA molecule, so that each protein has a well defined amino acidic sequence, 
indicated as the "primary structure". Each protein's residue is made of a central C-alpha carbon 
covalently bound to an amminic group, an acidic group - which together form the protein 
backbone - and a variable side-chain.  
The first two groups are condensed together by a peptide bond, which has partial double-bond 
behaviour due to the resonance between a neutral and a charged conformation. This 
characteristic does not allow the rotation of the bond itself, so that the residues' C-alphas are 
almost coplanar [1]. Additionally, due to sterical constraint between the CO and NH groups, the 
peptide bond reduces the degree of freedom of the backbone, which can rotate only around the 
two dihedral angles phi and psi, defined between N-C-alpha and C-C-alpha respectively. The 
value of these angles can be distributed only within a finite set of combinations, traditionally 
described by the so called "Ramachandran plot" and recently refined by Ting and colleagues [2].  
The variable side-chain is used to identify the amino acids in 20 "standard" types and to classify 
them in different chemical categories based on several properties, like for example charge or 
size. However, they can be broadly categorized in hydrophobic (non-polar) and hydrophilic 
(polar). Hydrophobic residues do not interact favourably with water molecules, so they are more 
often found in the core of a water-soluble protein; for the opposite reason, hydrophilic amino 
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acids can be exposed to the solvent - where an interaction with small molecules can occur - or 
can be located in the protein core, where they contribute to the structural stability of the protein 
by forming salt bridges with other residues [3]. Moreover, some residues have particular 
features. For example, cysteine can bind another residue of the same type to form disulfide 
bridges; glycine confers more flexibility to the surrounding structure as has only a hydrogen atom 
as side-chain; finally, proline has a cyclic structure that increases the conformational rigidity of 
the backbone.  
The variability in residues chemical properties and in their position along the protein sequence 
determines the structure and the biological function of the protein itself. Each residue can 
interact with the other amino acids by different non-covalent bonds, which might be hydrogen 
bonds, ionic bonds or Van der Waals interactions; all of these are weaker than a typical covalent 
bond, but they can act together to create a strong bonding network. The hydrogen bond in 
particular is involved in the stability of the two simplest and common structural patterns that can 
be found in proteins, that is, the alpha-helix and the beta-strand [4].  
The first is a right-handed helical conformation characterized by a hydrogen bond present every 
four residues between the CO and the NH groups of the backbone, creating a complete turn 
every 3.6 amino acids. Left-handed helices exist in nature, but they are less energetically 
favourable because of the steric clashes between the backbone and the side-chains. Usually 
alpha-helices can range from four to forty residues in length and are more frequent in proteins 
that cross a lipid membrane.  
The beta-strand, instead, is a fully extended backbone region characterized by several hydrogen 
bonds between the CO and the NH groups of residues located further apart in the protein 
sequence than in the alpha-helix. Two or more strands can organize themselves in a beta-sheet, 
with a twisted and pleated shape, where the side-chains are oriented to both sides of the sheet. 
In the parallel beta-sheets, the strands point to the same direction; in anti-parallel beta-sheets, 
strands point to opposite directions; finally, in mixed beta-sheets, both strand directions are 
present. Alpha-helices and beta-strands are connected by loops, which are structural motifs that 
do not create a regular pattern and in which the involved residues are positioned in close 
proximity.  
These three structural units (helices, strands and loops) constitute the "secondary structure" of a 
protein and the combinations of these elements are known as "protein folds". From the 
functional point of view, groups of secondary structures can give rise to three-dimensional 
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elements, named "domains", which are able to fold in a stable manner independently from the 
rest of the protein. Proteins might contain several domains, whose length usually ranges from 40 
to 350 residues, and the same type of domain - which defines a particular function - may appear 
in a variety of different proteins [3].  
Tertiary and quaternary structure 
The next level of complexity is defined by the "tertiary structure", which refers to the overall 
three-dimensional structure of a protein chain. The tertiary structure is the result of a 
thermodynamical process, called "protein folding", which is guided by the cooperative interaction 
of the residues. The forces driving this process are mainly hydrogen bonds [5] and hydrophobic 
effects, in which the non-polar side-chains tend to pack within the protein core in order to avoid 
any exposition to the surrounding water [6]. 
Some proteins are able to function as single chains and, therefore, they are indicated as 
―monomers‖; however, many others need to assemble in complexes called ―oligomers‖, which 
are stabilized by non-covalent bonds interacting at the chains interfaces. When these 
assemblies are composed of many copies of the same chain, they are called "homo-oligomers"; 
otherwise, assemblies consisting of at least two different chains are indicated as "hetero-
oligomers". This level of structural organization is referred to as the "quaternary structure" of a 
protein, while the single chains are called "subunits". A summary of all protein structural levels is 
shown in Figure 1.1.  
Protein oligomers perform, or regulate, their function by changing the conformation of individual 
chains or their relative orientation to each other. One example of this behaviour is haemoglobin, 
a hetero-oligomer in which the allosteric regulation of its function is achieved by the relative 
orientation of the subunits [7]. 
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Figure 1.1 Illustration of the hierarchical structural levels of a protein. From Wikipedia, retrieved 2014 
March 31, from http://en.wikipedia.org/wiki/Protein_structure  
Experimental techniques to determine protein structure 
The most important experimental methods to decipher the above mentioned structural levels of a 
protein are X-ray crystallography [8], Nuclear Magnetic Resonance spectroscopy (NMR) [9] and 
Electron Microscopy (EM) [10]. 
In the X-ray crystallography, a purified protein crystal is irradiated with X-ray beams in order to 
reconstruct the precise atom positions. The directions and intensities of the X-rays which are 
diffracted by the electrons in the crystal are measured from the so called "diffraction pattern", 
which can be converted, through a Fourier transform, to an electron density map. By combining 
the knowledge about the target amino acidic sequence with proteins‘ geometrical constraints, it 
is possible to reconstruct atom positions and to build a model of the protein. Although producing 
high-quality crystals is a time-consuming process and membrane proteins in particular do not 
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crystallize, the X-ray crystallography is still considered the gold standard method mainly because 
of its high accuracy and for the fact that the protein function is preserved in the resulting crystal 
[8]. 
In NMR spectroscopy, the magnetic properties of the atom nuclei are used to determine the 
structure and the dynamics of a target molecule. The proteins, usually suspended in a buffer 
solution, are placed within a strong magnetic field and irradiated with varying radio wave pulses. 
The measured variable is the resonance of the nuclei possessing a spin, i.e. those which 
produce a magnetic moment, like hydrogen (1H), carbon (13C) and nitrogen (15N). Depending 
on the atom type, on the surrounding atoms and on their distances, the resonance frequency of 
an atom can change and this information is used to infer the structure of the target molecule [9]. 
The electron microscopy method uses a beam of electrons to illuminate a sample and to 
produce a magnified image, which has a much higher resolution than an image produced with 
conventional light. This technique is based on the high scattering power of electrons; for this 
reason, the sample must be a very thin crystal. Moreover, the possibility to focus the electrons 
by an electric or magnetic field allows retaining the crystallographic phase information in the 
resulting image. However, biological material is sensitive to radiation and, for this reason, the 
electron dose must be limited, at a cost of a small signal to noise ratio. The most used approach 
to create an image is the single particle averaging, in which several 2D images of the molecule 
densities are collected and averaged; then, by applying a back projection in real space, the three 
dimensional density of the sample is assembled. A second approach, in which the diffraction 
pattern of a two-dimensional crystal is produced, is more commonly applied to determine the 
structure of membrane proteins. The main limitation of electron microscopy consists in the need 
of a relatively large array of ordered macromolecules to achieve a resolution around 3.5 
Angstroms [10]. 
The structural data of biological macromolecules obtained through any of the three techniques 
described above is deposited by experimentalists in the database "Protein Data Bank" (PDB) 
[11]. At the moment of its inauguration, in 1971, the PDB contained only 7 structures, but since 
1980 the number of entries started to increase substantially. The reason of this growth mainly 
resided in the improvement of the crystallographic techniques and in the emergence of new 
methods to determine the structure of a protein, as for instance NMR. Recently, structural 
genomic initiatives like the Protein Structure Initiative are increasing even more the number of 
deposited structures, which has reached almost 100'000 entries. Apart from atomic coordinates, 
other types of information are deposited in the PDB, including experimental details, raw density 
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maps and quaternary structures, to name a few. To increase the robustness of the service to the 
public, three mirror sites are available: RCSB [12], PDBe [13] and PDBj [14]. Finally, since 
several structures were deposited long ago and were refined with different types of algorithms, 
an updated and optimized version of the PDB entries is now available through PDBredo [15]. 
Ligand binding sites 
Apart from the role played by the structural conformation, a critical element that defines the 
function of a protein is the ―binding site‖, that is, the portion of the protein surface through which 
it interacts with either other proteins or small non-protein molecules, for example ions, organic 
ligands or nucleic acids. These interactions can be stable, i.e. they are required to stabilize the 
structure and to perform the function (for instance, in the case of quaternary assemblies), or 
transient, as for example, when the protein binds to the substrate during an enzymatic reaction 
or to a signalling molecule (as in Figure 1.2). 
Knowing the ligands bound by a protein and the residues involved in these interactions can 
provide a significant help in the identification of the protein function and in the understanding of 
its mechanism of action at the atomic level. Moreover, the information regarding the ligand 
preferences of a protein can constitute a valuable insight for protein mutational experiments, 
structure-based drug design and virtual screening. 
 
Figure 1.2 (A) The protein folding shapes and brings together a group of residues that constitute the 
protein binding site. (B) An example of the molecular interactions, hydrogen bonds and ionic interactions, 
between a small molecule (in pink cyclic AMP) and a protein binding site. From [16]. 
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Protein structure prediction 
Sequence-structure gap 
The dependency of the protein's three-dimensional structure on its sequence was revealed for 
the first time by the work of Anfinsen [17], in which he performed denaturation experiments on 
the ribonuclease enzyme showing the relationship between the conformation of a protein and its 
biological function. The major finding of Anfinsen consisted in the fact that the enzyme in a 
denaturated (or unfolded) state spontaneously regained its native activity under particular buffer 
conditions. More in particular, a pivotal role in the transition to the functional conformation of the 
enzyme was played by a decrease in free energy of the system. Afterwards, similar experiments 
showed that, while many proteins can fold in their native state under proper conditions, other 
proteins need the help of assistant proteins, called "chaperons", to reach the correct 
conformation and to avoid uncontrolled aggregation within the cell.  
The relationship between the sequence and the structure was further investigated by the work of 
Chothia and Lesk [18], who showed a non-linear correlation between the divergence of the 
protein sequence and the structure core in a set of evolutionary related proteins solved by X-ray 
crystallography (Figure 1.3). This observation implicated that the success of protein structure 
prediction involving evolutionary related sequences depends on the extent of the sequence 
identity between the target protein and its homologs. However, because of convergent evolution, 
even a distantly related protein with overall low sequence identity to the sequence of interest can 
turn out to be a useful template for modelling the active site [18]. 
Despite the rapid increase in the number of experimentally determined structures, the number of 
sequences identified by Next-Generation Sequencing (NGS) techniques grows even faster. 
Consequently, the difference between protein structures and sequences, also called "sequence-
structure gap", is constantly widening. Structural genomic initiatives, as for instance the Protein 
Structure Initiative (PSI) [19], are trying to reduce the uncovered protein space by determining 
the structures of proteins with less than 30% sequence identity to existing structures. In the 
attempt to fill the sequence-structure gap, several computational methods were developed for 
building models of proteins with still unknown structure; these can be classified in "de novo" 
methods, in which a candidate structure is selected from a set of pre-generated models, and 
"template-based" approaches, which adopt the sequence-to-structure relationship to find the 
best structure for a given protein sequence. 
14 
 
 
Figure 1.3 The non-linear correlation between the residue identity percentage and the root mean squared 
deviation in the common cores of the backbone atoms from 32 pairs of homologous proteins. 
Template-based structure prediction 
The template-based structure prediction methods take advantage of existing structures to 
generate a model of a protein, also called "target", at atomic resolution, weighting more 
evolutionary information than physics-based energy functions. The first step of this procedure is 
the identification and alignment of sequences taken from the structures found to be evolutionary 
related to the target protein. In the next step, the target sequence is modelled on the selected 
structure, called "template", and the model is subsequently refined. Finally, the quality of the built 
model is evaluated in order to assess whether the model is reliable or not. In case of a negative 
answer, the above procedure must be repeated to find a suitable model [20].  
The initial step of the prediction is the most crucial one, since it significantly affects the quality of 
the model; previously, it was performed by local alignment tools, for example BLAST [21], which 
can be used to generate accurate alignments when the sequence identity between the target 
and the templates is above 50%. Below this threshold, more sensitive and sophisticated 
methods based on sequence-profile [22], sequence-HMM [23] or HMM-HMM [24] alignments 
showed to be more successful. Protein threading methods can be applied in case only remote 
homologs are found and, in particular, for homologs with sequence identity in the range called 
―twilight zone‖ [25]. An example of a tool implementing this approach is RaptorX, which assigns 
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more weight to the sequence features when a high sequence identity is measured, while it gives 
higher priority to the structural properties in case of remote structures [26].  
After a template and its alignment are selected, these are used to generate the three-
dimensional coordinates of the target protein. The main approaches employed during this stage 
can be divided in "fragment assembly" and "satisfaction of spatial restraints". According to the 
former method, the conserved structural elements are initially copied from the template and, in a 
later stage, the variable regions are remodelled; instead, in the satisfaction of spatial restraints 
method (an example of which is the software MODELLER [27]), the probability density function 
derived from geometrical criteria are used as spatial constraints to drive the global energy 
minimization of the model's atom coordinates. Overall, the higher is the sequence identity 
between the target and the template, the more successful become template-based approaches. 
De novo structure prediction 
The de novo structure prediction infers the structure of a protein either on the basis of the 
principles that guide molecular interactions, or by doing a statistical analysis of the native 
structure conformational features. In the former case, the method of prediction is named 
―physics-based‖, while in the latter the method is called ―knowledge-based‖. In general, the de 
novo approach samples the structural conformational space by using a scoring function based 
on one of the two above mentioned methods and generates a set of candidate structures, called 
―decoys‖, which are then filtered to select the native-like conformations. Even though the de 
novo approach does not achieve fold level quality in many cases [28], a successful example of 
this procedure is represented by ROSETTA [29]. Finally, although template-based methods are 
preferred when a suitable template is found, de novo methods can be useful for modelling 
targets with none or low template coverage, as well as for model refining. 
Ligand binding site prediction 
Several approaches of binding site prediction have been proposed in the last decade; these can 
be subdivided on the basis of the main information employed, which can be: target sequence 
conservation [30-35], protein surface geometry [36-42] or functional annotation from evolutionary 
related proteins [43-49]. Depending on the available data, different methods can be applied. In 
case the structure of the target protein is unknown or cannot be modelled, only the sequence 
conservation-based approach can be used; otherwise, the clefts on the protein surface can be 
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investigated to identify potential ligand binding sites; finally, the functional annotation-based 
methods can only be used in case homologous proteins are found. 
In the approach last mentioned above, the fundamental steps of ligand binding site prediction 
consist in: (i) finding the target's homologs, (ii) identify their functional sites, (iii) determine the 
corresponding residues in the target and (iv) transfer to these residues the annotations found for 
the homologs. While some methods rely on the alignment between the target and the 
homologous sequences (for example [43]), others superpose the homologous structures to the 
target model (as in [44, 46, 48, 49]) to identify the functional residues in the target and to transfer 
the available annotation. 
To assess the performances of these different methods, each two years the Critical Assessment 
of protein Structure Prediction (CASP) Function prediction (FN), evaluates the accuracy of the 
participant methods. Recently, algorithms based on the homology transfer approach have shown 
excellent results in the ligand binding site prediction [50, 51]. To tackle the challenges involved in 
the precise evaluation of binding site predictions emerged during the last CASP editions, an 
automated server, the Continuous Automated Model EvaluatiOn (CAMEO) Ligand binding site 
for the ligand binding site prediction assessment was developed (http://cameo3d.org/lb/). 
Objectives 
The main focus of this thesis is to improve the information contained in the models built by the 
SWISS-MODEL server, by introducing a new ligand modelling pipeline. Secondly, we examined 
and assessed the current methods available for predicting binding sites and for modelling 
ligands into protein models.  
In the next chapters, we first show our assessment of the current state-of-the-art methods for the 
CASP9 and CASP10 editions. Then, we describe the method developed to assess the 
predictions of the servers registered to CAMEO. Afterwards, we illustrate the approach used for 
ligand modelling and implemented in SWISS-MODEL. Finally, we describe a method to 
represent binding site geometries, called ―moment invariants‖, which we studied to develop a 
future de novo ligand binding site predictor.  
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Tiziano Gallo Cassarino1,2, and Torsten Schwede1,2. Proteins, 2011. 79 Suppl 10: p. 126-36. 
1. Biozentrum, University of Basel, Switzerland 
2. SIB Swiss Institute of Bioinformatics, Basel, Switzerland 
Contribution: I analysed the targets and assessed the biologically relevance of their ligands. 
Abbreviations 
MCC: Matthews‘ Correlation Coefficient 
TBM: Template-Based Modelling 
FM: Free Modelling 
Abstract 
Interactions between proteins and their ligands play central roles in many physiological 
processes. The structural details for most of these interactions, however, have not yet been 
characterized experientially. Therefore, various computational tools have been developed to 
predict the location of binding sites and the amino acid residues interacting with ligands. In this 
manuscript, we assess the performance of 33 methods participating in the ligand binding site 
prediction category in CASP9. The overall accuracy of ligand binding site predictions in CASP9 
appears rather high (average MCC of 0.62 for the ten top performing groups), and compared to 
previous experiments more groups performed equally well. However, this should be seen in 
context of a strong bias in the test data towards easy template based models. Overall, the top 
performing methods have converged to a similar approach using ligand binding site inference 
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from related homologous structures, which limits their applicability for difficult ―de novo‖ 
prediction targets. Here, we present the results of the CASP9 assessment of the ligand binding 
site category, discuss examples for successful and challenging prediction targets in CASP9, and 
finally suggest changes in the format of the experiment to overcome the current limitations of the 
assessment. 
Introduction 
To perform their functions, proteins interact with a plethora of small molecules within the cell. 
Most of these interactions are unspecific and transient in nature (e.g. interactions with water and 
ions), some are persistent and may play a structural or functional role (e.g. certain metal ions), 
and others might be transient but nevertheless highly specific, often resulting in essential 
changes of the protein or the ligand (e.g. enzyme-substrate complexes or receptor-ligand 
complexes). Hence, the identification of a protein‘s functionally important residues, such as 
ligand binding sites or catalytic active residues, is a crucial step towards the goal of 
understanding the protein‘s molecular function and its biological role in the cell. Although protein 
ligand interactions are crucial for the function of a protein, in many cases they are unknown. 
While the kind of ligands interacting with a protein is often known from biochemical analyses, 
elucidating the structural details of these interactions requires elaborate and time-consuming 
studies by X-ray crystallography or NMR. Therefore, computational tools have been developed 
aiming at predicting the precise location of binding sites, and specifically which amino acid 
residues in a protein are directly interacting with ligands. Various approaches for the prediction 
of ligand binding sites have been proposed,[1] both from structure and from sequence, based on 
sequence conservation [2-7], geometric criteria of the protein surface [8-12] or homology transfer 
from known structures.[13-17] 
The function prediction category (FN) was introduced in the 6th Critical Assessment of Protein 
Structure Prediction (CASP), where predictions for Gene Ontology molecular function terms, 
Enzyme Commission numbers, and ligand binding site residues were evaluated. [18, 19] Since 
very little new functional information becomes available during and after the experiment, the first 
two categories were difficult to assess. Therefore, since CASP8 the prediction task has been to 
identify functionally important residues such as ligand binding residues or catalytic residues. [20] 
Here, we present the assessment of 33 groups participating in the recent CASP9 experiment. In 
the ligand binding site prediction category (FN), the sequence of a protein with unknown 
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structure was provided to predictors. The task was to predict the residues directly involved in 
ligand binding in the experimental control structure. This approach differs significantly from 
typical ligand binding studies (like docking or virtual screening), where the chemical identity of 
the ligand is given, and the correct geometric orientation of the molecule in the receptor protein 
is to be determined. [11, 21-24] In CASP however, the chemical identity of the ligand is unknown 
at the time of prediction, and only the interacting residues are predicted. 
In summary, all top performing groups have applied a similar approach, using ligand information 
derived from homologous structures in the PDB.[25] In comparison to CASP8 [20], we could not 
observe a significant progress by the top groups, but rather a larger number of groups 
performing at the same level. We believe that this observation is caused on one side by the bias 
in the data set to ―easy‖ template based predictions with only a very small number of difficult ―de 
novo‖ targets in recent rounds of CASP. This gives strong advantage to methods using PDB 
information directly, but discourages the development of methods addressing the more 
challenging ―de novo‖ cases. Another limiting factor is the binary format of the prediction task, 
which does not allow specifying probabilities for specific residues or differentiating between 
types of ligands. 
Materials and Methods 
Prediction targets 
All CASP9 target structures were analyzed for non-solvent non-peptidic ligand groups in the 
deposited protein structures. Based on literature information, UniProt [26] annotations, structures 
of closely related homologues (Table SI, Supplementary Information), and conservation of 
functionally important residues, we aimed at identifying ligands with biological / functional 
relevance for the specific protein. All targets, including those containing ligands classified as 
―non-biologically relevant‖, were further analyzed to indentify cases where a ligand clearly 
mimicked the interactions of known biologically relevant ligands for this target. 
Binding site definition 
For each prediction target, binding site residues were defined as those residues in direct contact 
with the ligand in the target structure, i.e. all protein residues with at least one heavy atom within 
a certain distance from any heavy atom of the ligand. The distance cutoff was defined by the 
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CASP organizers as the sum of the Van der Waals radii of the involved atoms plus a tolerance 
of 0.5 Å. In addition, different tolerance values ranging from 0 to 2.0 Å were evaluated. 
In cases where multiple chains with bound ligands were present in the target structure (e.g. 
homo-oligomeric assemblies), the definition of the binding site residues for individual chains 
were combined into a single binding site definition. For targets where ligands were observed to 
bind in the interface between multiple chains, the oligomeric structure as defined by the authors 
and PISA [27] (5 cases) or only PISA (1 case) was used for the binding site definition. Analysis 
of structures and ligand binding sites were performed using OpenStructure (version 1.1). [28] 
For targets in which only part of the relevant ligand was present, the binding site definition was 
extended to include the entire biologically relevant ligand. In these cases, two separate 
evaluations of the prediction performance were conducted. The first, denoted as ‗extended 
binding site‘, all atoms of the partial and the extended ligand were used to define the binding site 
in the same way as described above. The second, denoted as ‗partial binding site‘, only atoms of 
the partial ligand were used to define the binding site, whereas all residues exclusively in contact 
with the extended part of the ligand were treated as neutral and excluded from the evaluation. 
Binding site prediction evaluation 
As in the previous assessment,[20] binding site prediction performance was measured using the 
Matthews Correlation Coefficient[29] (MCC) which accounts both for over and under predictions. 
For each target, residue predictions were classified as true positives (TP: correctly predicted 
binding site residues), true negatives (TN: correctly predicted non-binding site residues), false 
negatives (FN: incorrectly under predicted binding site residues), false positives (FP: incorrectly 
over predicted non-binding site residues) based on the binding site definition described before. 
The MCC was computed using Eq. 1: 
)()()()( FNTNFPTNFNTPFPTP
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The MCC ranges from +1 (perfect prediction) over 0 (random prediction) to -1 (inverse 
prediction). Empty submissions which did not include any binding site predictions and missing 
predictions were assigned a MCC score of zero. 
To reduce the effects of target difficulty on the ranking, MCC scores were standardized by 
computing Z scores among all predictions P for a given target T using Eq. 2: 
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In this equation, MCCP,T is the raw MCC score for target T given by predictor P, 𝑀𝐶𝐶𝑇         is the 
mean MCC score for target T, σT is the standard deviation of MCC scores for target T. The 
overall performance for each predictor was computed as the mean of Z scores over all targets, 
which was subsequently used for obtaining a final ranking.  
In addition to the MCC score, we computed the recently published binding site distance test 
(BDT) [30]. BDT takes the actual three dimensional locations of the predicted residues into 
account and scores residues differently, according to the distance between the predicted and the 
observed binding site. Predictions close to the binding site score higher than more distant 
predictions. The BDT score ranges from 0, for a random prediction to 1, for a perfect prediction. 
Robustness and significance 
Statistical significance of the ranking and robustness with regard to composition of the target 
data set was assessed using two different methods. First, two-tailed Student‘s paired t-tests as 
well as Wilcoxon signed rank tests [31] between all predictor groups were performed based on 
MCC scores for each target. Both T-tests and Wilcoxon signed rank tests were performed using 
R (version 2.11.1). [32] Second, bootstrapping was performed, where scores were computed on 
a randomly selected subset of ¾ of all targets (i.e. 23 of 30 targets). 75 rounds of bootstrapping 
were executed for different target subsets, and for each bootstrapping experiment, mean, 
minimum and maximum Z scores per group were calculated as previously described. 
Additionally, the rank for each prediction group was calculated and mean, minimum and 
maximum ranks over all bootstrapping experiments were computed. 
To assess the performance of groups on different types of ligands, we have analyzed the 
prediction performance separately on targets including only metal ions (10 targets) and on 
targets including only non-metal ligands (17 targets). Mixed targets including both metal and 
non-metal ligands (3 targets) were not considered in this sub-analysis. 
Results and Discussions 
Overall performance 
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In the CASP9 protein binding sites prediction category (FN), the predictors were given a protein 
sequence with unknown structure and asked to identify the residues involved in ligand binding. 
According to the CASP format, the predictions were binary and thus, classified each residue as 
either binding-site or non-binding-site residue. As defined by the organizers, only protein-small 
molecule interactions were considered in this category. The assessment of this category 
consisted of the following three steps: (1) identification of biologically relevant ligands in the 
target structures, (2) definition of binding site residues, (3) assessment of the prediction 
performance. 
One dominant factor in assessing the correctness of ligand binding site prediction is the 
availability of experimental data, and the evaluation of the biological relevance of the specific 
ligand binding. Whether a certain ligand is observed in an experimental structure is first and 
foremost determined by the specific purification procedure, by the experimentalist‘s choice of 
using this ligand for a co-crystallization experiment, and the specific experimental conditions 
(ligand concentration, pH and buffer conditions, ionic strength, precipitant etc.). If a ligand is not 
observed in a specific experimental structure, it could still bind under different conditions, i.e. it 
cannot be considered as a ―true negative‖ data point for the assessment. On the other hand, if a 
certain ligand is observed in a target structure, we can classify the residues within this structure 
into ―binding‖ and ―non binding‖ with regard to this specific ligand. Note that a target protein 
might be able to bind different ligands under different experimental conditions, and only a subset 
of them might be present in the target structure at hand. For example, the structure of an 
enzyme might be crystallized in complex with the cofactor, but without substrate or product 
molecules.  
Although the identification of ligands in CASP9 was based only on experimentally observed 
ligands, it was still not straightforward to categorize their biological relevance. Although in 73% 
of the target structures in CASP9 various ligands were present, most of them were not 
considered biologically relevant but rather as originating e.g. from solvent, crystallization 
precipitant, or buffers. For the assessment, however, we included only ligands which we 
considered to be biologically relevant. The decision on biological relevance was done by manual 
curation, primarily based on the type and location of the ligand, literature information, and 
UniProt[26] annotations. In addition, information from structurally closely related homologues 
and conservation of functionally important residues was used to guide the selection process. 
Using this approach, 16 target structures with biologically relevant ligands were selected out of 
the 109 targets available in CASP9 for the assessment. 
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In addition, we have analyzed all remaining heteroatomic groups, if they occupied binding sites 
which mimicked the interactions of a known biologically relevant ligand for this protein. In these 
cases, we defined an ―extended binding site‖ consisting of all residues in contact with the known 
biologically relevant ligand. We were careful to include only targets where the assignment was 
unambiguous, in order to avoid the inclusion of false binding site definitions. Using this 
approach, the number of target structures in the FN category was extended by 14, yielding a 
total of 30 targets in this category (Table I). 
Table I Summary of CASP9 targets with bound ligands. 
Target PDB 
Partial  
Ligand 
Extended 
Ligand 
Chemical Class Interface 
CASP 
Category 
T0515 3MT1 SO4 PLP, LYS Non-metal A-B TBM 
T0516 3NO6 IMD PF1 Non-metal  TBM 
T0518 3NMB NA  Metal  TBM 
T0521 3MSE CA, CA  Metal  TBM 
T0524 3MWX GOL GAL Non-metal  TBM 
T0526 3NRE PEG GLA Non-metal  TBM 
T0529 3MWT MN  Metal  TBM 
T0539 2L0B ZN, ZN  Metal  TBM 
T0547 3NZP PLP PLP, LYS Non-metal A-B TBM 
T0548 3NNQ ZN  Metal  TBM 
T0565 3NPF CSA DGL, ALA Non-metal  TBM 
T0570 3NO3 MG, GOL  Metal, Non-metal  TBM 
T0582 3O14 ZN  Metal  TBM 
T0584 3NF2 SO4 DST, IPR Non-metal  TBM 
T0585 3NE8 ZN  Metal  TBM 
T0591 3NRA LLP  Non-metal A-B TBM 
T0597 3NIE ANP  Non-metal  TBM 
T0599 3OS6 SO4 ISC Non-metal  TBM 
T0604 3NLC FAD  Non-metal  TBM / FM 
T0607 3PFE ZN ZN, BES Metal, Non-metal  TBM 
T0609 3OS7 TLA GAL Non-metal  TBM 
T0613 3OBI EDO GAR, NHS Non-metal  TBM 
T0615 3NQW MN, SO4 MN, GPX Metal, Non-metal  TBM 
T0622 3NKL SO4 NAD Non-metal  TBM 
T0625 3ORU ZN  Metal  TBM 
T0629 2XGF 
FE, FE, FE, FE, FE, 
FE, FE 
 Metal A-B-C FM 
T0632 3NWZ COA  Non-metal A-B-C TBM 
T0635 3N1U CA  Metal  TBM 
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T0636 3P1T TLA HSA, PLP Non-metal A-B TBM 
T0641 3NYI STE  Non-metal  TBM 
 
Within the selected targets, ten were found in complex with metal ions (Ca, Fe, Mg, Mn, Na, Zn), 
and further 17 targets in complex with non-metal ligands (Table I). The latter included amino 
acids and derivatives, nucleotides, sugars, fatty acids and others. Additionally, in three cases 
non-metal ligands were coordinated to metal ions (Mg, Mn, Zn). In most of the targets, the ligand 
binding site was located within a monomer, while for six targets the ligand was bound in the 
interface between multiple chains: T0515, T0547, T0591, T0636 (dimeric structures), T0629 
(trimeric structure) and T0632 (tetrameric structure). The ligands were bound between all chains 
of the oligomeric structure, except for T0632 where the ligand is bound to only three of the four 
chains. Following the identification of biologically relevant ligands, the binding site residues for 
those targets were defined as those residues directly in contact with the ligand. Atoms were 
considered to be in contact if they were within a distance of the sum of their van der Waals radii 
plus a tolerance distance.  
The list of binding site residues used in the assessment for each target is provided in Table SI 
(Supplementary Material). The tolerance distance was defined as 0.5 Å by the CASP organizers. 
We tested the influence of different values for the tolerance distance of the binding site definition 
and their influence on the assessment of prediction performance. No significant differences in 
the overall prediction performances were observed for different tolerance distances (Fig. S1, 
Supporting Information).  
The majority of FN targets in CASP9 were classified as template based modeling targets (TBM), 
and only two targets were free modeling (FM) targets: (1) target T0629, where the ligand binding 
domain had no template structure (Fig. 8C), (2) target T0604, where the ligand was bound 
between two domains where one was a template based modeling (constituting 90% of the 
binding site residues) and one a free modeling domain (constituting 10% of the binding site 
residues). This strong bias in the data set has direct consequences for the assessment, as it is 
to be expected that template-based prediction methods will perform much better than ―de novo‖ 
methods in this context. 
In total, 33 groups made predictions in the CASP9 FN category. A summary of the predictions is 
given in Figure 1. Among the participating groups, 18 were registered as ―human predictors‖ and 
15 as ―servers‖ (Table II). Most groups predicted at least 25 of the assessed 30 targets, i.e. 12 
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groups (6 humans, 6 servers) predicted between 25 and 29 of the assessed targets and 15 
groups (6 humans, 9 servers) predicted all 30 targets; 6 human groups returned predictions for 
only 6 or less targets. Binding site prediction performance was measured using Z-scores of 
Matthews correlation coefficients (see Methods).1  
 
Figure 1. Overview of predictions per group. Predictions for targets which were assessed in the FN 
category (i.e. targets with a relevant binding site) are displayed in dark colours, additional predictions 
which were not assessed (i.e. targets without an experimentally confirmed binding site) are displayed in 
light colours. Human groups are shown in purple, servers in orange. 
Table II Groups participating in the FN category in CASP9. 
ID Rank Name Type Group 
 FN017 22 3DLIGANDSITE1 S Michael Sternberg 
 FN035 5 CNIO-FIRESTAR H Gonzalo Lopez 
 FN057 21 3DLIGANDSITE3 S Michael Sternberg 
 FN072 23 3DLIGANDSITE4 S Michael Sternberg 
 FN094 8 MCGUFFIN H Liam McGuffin 
 FN096 1 ZHANG H Yang Zhang 
 FN097 30 KOCHANCZYK H Marek Kochanczyk 
 FN102 15 BILAB-ENABLE S Shugo Nakamura 
 FN104 7 JONES-UCL H David Jones 
                                               
1
 As described in Materials and Methods, the authors decided that assigning a MCC score of zero to empty submissions which did 
not include any binding site predictions and to missing predictions would most appropriately reflect a ―real life‖ prediction situation in 
the assessment. Please note that this policy has consequences for the final ranking as it penalizes methods which are not able to 
make predictions for some targets, and encourages the risky development of novel methods as there is no implicit penalty for making 
predictions for challenging targets. 
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 FN110 6 STERNBERG H Michael Sternberg 
 FN113 9 FAMSSEC H Katsuichiro Komatsu 
 FN114 10 LEE H Jooyoung Lee 
 FN132 27 MN-FOLD S Chris Kauffman 
 FN147 28 GENESILICO H Janusz Bujnicki 
 FN154 33 JAMMING H Gabriel del Rio 
 FN193 24 MASON S Huzefa Rangwala 
 FN207 26 ATOME2_CBS S Jean-Luc Pons 
 FN236 12 GWS S Jooyoung Lee 
 FN240 32 TMD3D H Hiroshi Tanaka 
 FN242 4 SEOK H Chaok Seok 
 FN303 20 FINDSITE-DBDT S Jeffrey Skolnick 
 FN311 31 ALADEGAP H Kei Yura 
 FN315 3 FIRESTAR S Gonzalo Lopez 
 FN316 18 LOVELL_GROUP H Simon Lovell 
 FN339 2 I-TASSER_FUNCTION S Yang Zhang 
 FN353 17 SAMUDRALA H Ram Samudrala 
 FN402 13 TASSER H Jeffrey Skolnick 
 FN415 25 3DLIGANDSITE2 S Michael Sternberg 
 FN425 19 INTFOLD-FN S Liam McGuffin 
 FN446 16 KIHARALAB H Daisuke Kihara 
 FN452 11 SEOK-SERVER S Chaok Seok 
 FN453 14 HHPREDA S Johannes Soeding 
 FN458 29 BILAB-SOLO H Mizuki Morita 
 
The comparison between all groups is shown in Figure 2 where the error bars indicate minimum 
and maximum Z scores obtained by bootstrapping on a randomly selected subset of three-fourth 
of the targets. The error bars indicate a fluctuation in the average Z score for each group. 
However, in case of a correlated movement in the score, this would not influence the groups 
ranking. Therefore, the rank for each prediction group was computed in each bootstrapping 
experiment and the average, minimum and maximum rank over all bootstrapping experiments is 
shown in Figure 3. 
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Figure 2. Mean Z scores over all targets for the top 20 predictor groups. Error bars show minimum and 
maximum average Z scores obtained from bootstrapping experiment. Human predictor groups are shown 
in purple, servers in orange. 
 
Figure 3. Mean rank based on bootstrapping experiment for the top 20 predictor groups. Error bars show 
minimum and maximum rank obtained from bootstrapping experiment. Human predictors are shown in 
purple, servers in orange. 
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The top 12 predictors clearly distinguished themselves from the following 21 groups and show a 
significantly better performance. Two predictors from the Zhang group (FN096, Zhang and 
FN339, I-TASSER_FUNCTION) show a better performance in terms of MCC compared to the 
following 10 groups, whereas the performance among those is comparable. Since many 
predictors seemed to perform similarly, statistical tests were used to assess the significance of 
the differences between these groups. Paired t-tests on all targets between all pairs of predictors 
were performed. The results are shown in Table III, with cells shaded according to computed P 
values. According to the t-test, the differences between the top ranked group (FN096, Zhang) 
and groups FN339 (I-TASSER_FUNCTION), FN242 (Seok) and FN035 (CNIO-Firestar) are not 
statically significant, while the differences between FN096 and the remaining predictors are 
significant. In addition, the non-parametric Wilcoxon signed rank test was performed, which 
yielded comparable results to the t-tests (Table SII, Supplementary Information). 
Recently, McGuffin and coworkers published an alternative binding site distance test (BDT) [30]. 
Opposed to MCC, BDT takes the actual three dimensional positions of the predicted residues 
into account and scores residues differently, according to the distance between the predicted 
and the observed binding site. Hence, BDT limits the boundary effects originating from 
ambiguous definition of binding sites. When applying the BDT score on the predictions (Fig. S2, 
Supporting Information), for the top ranked groups no significant deviations to the MCC based 
prediction assessment were observed. 2 
Table III. P-values computed by paired t-Test of all against all predictors. Significant differences 
between two groups are indicated by cells with white background. For clarity, only the 12 top performing 
predictors are shown, sorted by their overall performance. 
 FN096 FN339 FN315 FN242 FN035 FN110 FN104 FN094 FN113 FN114 FN452 FN236 
FN096 - 0.24 0.01 0.08 0.06 0.01 0.01 0.00 0.00 0.00 0.00 0.00 
FN339 0.24 - 0.27 0.20 0.28 0.20 0.05 0.04 0.02 0.05 0.02 0.02 
FN315 0.01 0.27 - 0.81 0.56 0.63 0.17 0.20 0.03 0.14 0.12 0.07 
FN242 0.08 0.20 0.81 - 0.85 0.90 0.31 0.28 0.27 0.19 0.10 0.09 
FN035 0.06 0.28 0.56 0.85 - 0.88 0.44 0.52 0.38 0.45 0.45 0.31 
FN110 0.01 0.20 0.63 0.90 0.88 - 0.33 0.28 0.27 0.30 0.33 0.18 
FN104 0.01 0.05 0.17 0.31 0.44 0.33 - 0.88 0.88 0.89 0.93 0.93 
FN094 0.00 0.04 0.20 0.28 0.52 0.28 0.88 - 0.99 0.98 0.94 0.79 
FN113 0.00 0.02 0.03 0.27 0.38 0.27 0.88 0.99 - 0.99 0.95 0.76 
FN114 0.00 0.05 0.14 0.19 0.45 0.30 0.89 0.98 0.99 - 0.96 0.56 
FN452 0.00 0.02 0.12 0.10 0.45 0.33 0.93 0.94 0.95 0.96 - 0.83 
FN236 0.00 0.02 0.07 0.09 0.31 0.18 0.93 0.79 0.76 0.56 0.83 - 
 
As described earlier, for 14 targets, the partial binding sites were individually extended around 
the observed ligand to reflect a binding site accommodating the most probable biologically 
                                               
2
 The largest change in ranking by 3 positions would be for group FN110. 
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relevant ligand. To investigate the influence of this extension, the assessment was performed 
both on all residues of the extended binding site and separately on all the residues of the partial 
binding site while treating the residues exclusively in the extended binding site as ―neutral‖ for 
the analysis. For the top ranked groups no significant differences in the overall prediction 
performances were observed between partial and extended binding site definitions (Fig.3 
Supporting Information)3.  
Assessment by type of binding sites 
In addition to the overall performance, subsets of the targets were evaluated individually, 
according to the ligand chemotype. The distinct chemical properties of metal ions and organic 
ligands give raise to diverse binding sites. Thus, it could be expected that various prediction 
methods perform differently. To address this question, we have analyzed the prediction 
performance separately on all targets including only metal ligands (10 targets) and on targets 
including only non-metal ligands (17 targets). The mean Z-score per group separated into metal 
and non-metal targets are shown in Figure 4. Within the top 10 groups most of them show a 
better performance for non-metal targets, with the exception of FN242 (Seok) and FN114 (Lee). 
Especially group FN114 shows a better performance on metal ligands, compared to an average 
performance on the full set of targets. 
Among the CASP9 FN targets, in six cases the ligand binds in the interface between multiple 
chains of an oligomeric protein complex. Although, the number of interface targets is very 
limited, we were interested in the question if the prediction of ligand binding sites of interface 
targets is more difficult than non-interface targets. We compared the average prediction 
performance, both according to mean MCC values, as well as the number of very good 
predictions (MCC > 0.85), for interface vs. non-interface targets. No significant difference was 
observed, thus on average, in those target categories it seems equally difficult to predict the 
binding site residues. However, it should be considered that four of the six targets are ―trivial‖ 
oligomers, where a simple blast query returns a homologues template-ligand complex with the 
correct oligomeric state. 
                                               
3
 The largest difference was observed for group FN113 which would change rank by 3 positions. 
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Figure 4. Mean Z scores of the top 20 groups, separated by the ligand chemotype. Metals are shown in 
blue, non-metals are shown in green. 
Human versus server prediction 
Looking at the top 10 groups, 8 of them were registered as ―humans‖, and only 2 as ―servers‖. 
Overall, there is a striking difference between the average performance of human groups and 
server groups with a mean Z score of 0.47 and 0.15, respectively. Although predictor groups 
registered as ―human‖ performed considerably better than ―servers‖, the role of human beings in 
the prediction process was difficult to evaluate.  
Several aspects seemed to contribute to this observation: Human predictors had access to 
multiple servers for structure modeling and various server binding site predictions, while server 
predictors have to rely on their own method only. While human predictors can make use of 
additional annotation from biological knowledgebases and scientific literature, servers have to 
rely on structured machine-readable information. A major bottleneck in this context seems the 
lack of consistent annotation of ligands found in PDB entries with respect to their biological 
relevance. It appears that human predictors benefit from the longer prediction time mainly by 
their ability to distinguish relevant from irrelevant ligand predictions. 
Prediction methods have converged to similar approach 
When comparing the methods of the top performing groups, it seems they have converged to 
similar approaches, which are based on homology transfer from related structures in the PDB. 
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By identifying homologous protein structures with bound ligands, putative binding site residues in 
the target model are classified by spatial proximity after alignment or superposition. The 
methods differ in their specific implementations with regards to the underlying structure 
databases (PDB vs. curated binding site libraries), target representation (alignment to structure 
vs. full atomic models), superposition to related structures to identify putative binding sites, and 
the use of residue conservation information in the prediction process.  
The major draw-back of these homology-based inference methods is that they rely on the 
availability of related protein structures with bound ligands and are thus unable to make 
predictions for novel proteins without prior ligand information. 
Although many groups have used similar approaches to make their predictions, we observed a 
surprising heterogeneity of performance within targets. As shown in Figure 5 (and Figure S4), 
the 12 top performing groups show overall a similar spectrum of results, with a few nearly 
perfectly predicted targets and some poorly predicted targets.  
 
Figure 5. MCC scores for the 12 top performing groups for all targets. Targets were sorted by their 
respective MCC score, individually for each group. 
Interestingly, when analyzing the results for individual targets, at least one good prediction was 
achieved across all groups (MCC value of at least 0.56; on average 0.84; see Fig. 6), and even 
predictors with a poor overall performance, can yield the best individual prediction for certain 
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targets, as shown in Figure 7. Thus, either the performance of the different methods is highly 
target specific, or there is a considerable random component in the prediction process in 
combination with a strong influence by the small and biased target data set. 
 
Figure 6. Overall target difficulty. MCC value of the best overall prediction for each target. 
 
Figure 7. Number of targets where a particular group returned the best prediction. Groups are sorted by 
their overall performance. For one target, multiple groups can perform equally. 
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Prediction examples 
Obviously, target T0604 was the most difficult target in the FN category in CASP9, with a 
maximum MCC score of 0.56 for the best prediction, and an average score of 0.29. The protein 
is a putative FAD dependent oxidoreductase with a bound FAD molecule (PDB: 3nlc). The 
protein is monomeric and forms a large binding pocket for the ligand. The structure is shown in 
Figure 8(A) together with the binding site predictions of group FN035 (CNIO-FIRESTAR) as one 
of the best predictions for this target. The top performing methods were able to accurately 
predict the lower part of the binding site around the adenine moiety, whereas all of them failed 
for the upper part of the binding site around the flavin moiety. This stems from the fact that this 
target structure has only remote homologues, which differ significantly in the flavin binding site 
region. This example clearly demonstrates the limitations of prediction methods that are based 
on homology transfer. 
Target T0629 is the only target in the current ligand binding target set which was classified as 
free modeling target and thus has no template structure. The protein (PDB: 2xgf) is the 
bacteriophage T4 long tail fiber receptor-binding tip. It contains a long fiber like structure which is 
formed by three chains and binds seven iron atoms. Each iron atom is complexed with six 
histidine residues. Each protein chain contributes two histidines to each binding site, where the 
two histidines are in a His-X-His motive, with X being any of Ser, Thr or Gly. The target structure 
is shown in Figure 8(C) together with the binding site predictions of group FN114 (LEE), the best 
predictor for this target among the top 10. Common to all predictions for this target is that they 
correctly predicted a subset of the seven binding sites – most likely due to local similarity to 
another metal binding protein with a His-X-His motif, but no predictor identified all sites correctly. 
The structure of target T0632 (PDB:3nwz) is a homo-tetramer which binds coenzyme-A. This 
ligand is interacting with three of the four chains of the protein, which seems to present a 
challenge for binding site residue prediction observed by a low average MCC of 0.22. An 
excellent prediction was obtained by group FN096 (Zhang) with an MCC of 0.72, which is 
depicted in Figure 8(B) along with the target structure. Many residues were well predicted 
despite originating from different chains. In this prediction, the largest errors originate from 
missing some binding site residues due to an elongated terminus compared to structurally 
closely related templates. 
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Figure 8. Examples of binding site predictions. All ligands are shown in spheres render mode. The protein 
backbone is shown in cartoon mode with each chain colored separately. All side chains of observed and 
predicted binding site residues are shown in licorice sticks. Correctly predicted residues (true positives) 
are colored in green, incorrectly under predicted binding site residues (false negatives) in yellow and 
incorrectly over predicted non-binding site residues (false positives) in red. (A) Target T0604 with 
predictions of group FN035. (B) Predictions of group FN096 for target T0632. (C) Group FN114‘s 
predictions for target T0629. 
Conclusion 
The task of predicting binding sites from a protein‘s sequence is of high relevance for life science 
research, ranging from functional characterization of novel proteins to applications in drug 
design, and consequently the ligand binding site prediction category in CASP has received 
increasing attention over the past years. In CASP9 it attracted a total of 33 predictors - ten more 
groups than in CASP8. In contrast to the previous CASPs, where only three predictors yielded 
reliable predictions,[20] in this assessment nearly half of the prediction groups yielded reliable 
predictions for the majority of targets. Two groups (FN096, Zhang; FN339, I-
TASSER_FUNCTION) performed better than the rest (when accounting for missing target 
predictions in the assessment), while the following ten prediction groups performed comparably 
well. This is not very surprising with respect to the observation that in this round all top 
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performing groups based their methods on approaches, which are similar to the best performing 
strategy in previous CASP experiments (i.e. Sternberg[33] and LEE[15]). 
Limitation of the current format and recommendations for future experiments 
The very low number of target structures with relevant ligands is a major limitation to the 
assessment as it does not allow to draw significant conclusions on the specific strengths and 
weakness of different prediction methods, e.g. with regard to target difficulty or type of the 
ligands. Only 30 of the total 109 CASP9 targets (28%) were considered to have a biologically 
relevant ligand bound in the target structures and were thus assessed in the FN category. It is 
likely that some of the remaining target proteins would bind interesting ligands under different 
experimental conditions, but such conclusions cannot be made with the available data. In the 
previous CASP8 experiment, the total number of targets in this category was 27, illustrating that 
this is a recurring problem - and not specific to this round of CASP. Another rather drastic 
limitation of the FN category is the binary prediction format which classifies residues as either 
ligand binding/non-binding based on a hard distance cutoff. Consequently, all ligands are 
currently treated uniformly, independent of their chemical type, and all potential binding sites are 
treated uniformly, independent of their affinity (or binding probability) for different ligands. 
Moreover, most targets in the FN category were straightforward TBM targets with numerous, 
closely related template structures, and only one of the 30 targets was categorized as free 
modeling (FM). However, exactly this class of target structures is of highest interest for 
computational ligand binding site prediction, where no obvious information about the location of 
their binding sites is available. We would like to suggest the following modifications to the 
assessment of ligand binding site predictions to enable the community to benefit even further 
from future rounds of this experiment: 
 In order to accumulate a sufficiently large number of prediction targets, the assessment 
of this category should be done continuously based on a weekly PDB pre-release. This 
would allow assessing the performance in different ranges of target difficulty, similar to 
other CASP categories, and facilitate analyzing the strengths and weakness of different 
approaches. During the CASP meeting in Asilomar, we have suggested that the CAMEO 
project (Continuous Automated Model EvaluatiOn) of the Protein Model Portal [34] could 
contribute to this effort. 
 Binding sites differ chemically and structurally from each other e.g. a metal ion binding 
site has different characteristics compared to e.g. a sugar binding site. We therefore 
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suggest that the assessment of binding site residue predictions should be made 
according to chemotype categories of the ligand expected to be bound. We would like to 
propose the following categories: ―metal ions‖ (e.g. Na, Ca, Zn, Fe, Mn, Mg, etc.), 
―inorganic anions‖ (e.g. SO4, PO4), ―DNA/RNA‖ for poly-ribonucleic acid binding sites, 
and ―organic ligands‖ for cofactors, substrates and receptor agonists/antagonists (e.g. 
NAD, FAD, ATP, SAM, CoA, PLP, etc.). More fine grained assessment categories might 
be necessary if more specific prediction methods emerge in the future. 
 The binary prediction of binding site residues should be replaced by a continuous 
probability measure, thus reflecting the likelihood for a residue to be involved in binding a 
ligand of a certain type. For example a certain residue might be predicted as having a 
high probability to bind a metal ion, but a low probability to bind an organic ligand. The 
assessment of continuous prediction variable (e.g. using ROC type analysis) would 
better reflect the spectrum of ―high affinity‖ and ―low affinity‖ sites of different types. 
 The experimentalist solving a protein structure typically will have more insights and 
experimental evidence for the biological role and relevance of ligands observed in a 
protein structure than the information which is publicly available to assessors during the 
CASP experiment. It would therefore be beneficial to capture the information about the 
biological role of ―HETATM‖ records during PDB deposition. 
Predicting binding sites from a protein‘s sequence has the potential for yielding high impact on 
life science research – if the predictions are specific and accurate enough to help addressing 
relevant biological questions. We hope that with the suggested modifications, the assessment of 
ligand binding site predictions will be more suited to evaluate the current state of the art of 
prediction methods, identify possible bottlenecks, and further stimulate the development of new 
methods. 
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Supplementary material 
 
Figure S1. Influence of different binding site definitions on the prediction performance of the top 12 
predictors. Mean Z score are shown for different tolerance distance used for binding site definition. All 
residues with a least one atom within the sum of the van der Waals radius plus the tolerance distance 
were considered to belong to the binding site. 
 
Figure S2. Comparison between the overall prediction performance evaluated using the Mathews 
Correlation Coefficient (MCC, in orange) and the Binding site Distance Test (BDT, in cyan). Overall 
prediction performance is shown in mean Z Scores over all targets. 
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Figure S3. Comparison of the overall prediction performance observed with the extended (red) and the 
partial (green) binding site definitions. Overall prediction performance is shown in mean Z Scores over all 
targets. 
 
Figure S4. MCC scores for all groups with at least 10 predictions for all targets. Targets were sorted by 
their respective MCC score, individually for each group. 
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Table SI Definition of binding site residues used in the assessment. [a] PDB id for the deposited 
target structure which was used to define the partial binding site. [b] PDB id of the protein structure related 
to the target structure, used in addition to define the extended binding site. 
Target Target 
PDB id [a] 
Related 
PDB id [b] 
Partial Binding Site Extended Binding Site Neutral Residues 
T0515 3MT1 1TWI 198, 199, 232, 233, 324 35, 37, 162, 198, 199, 230, 
232, 233, 269, 273, 324, 328 
35, 37, 162, 230, 269, 
273, 328 
T0516 3NO6 2QCX 44, 47, 48, 51, 113, 137, 
141, 208, 211 
44, 47, 48, 51, 113, 137, 138, 
141, 167, 171, 174, 208, 211 
138, 167, 171, 174 
T0518 3NMB  132, 133, 134, 162, 164, 
271, 273 
132, 133, 134, 162, 164, 271, 
273 
 
T0521 3MSE  48, 50, 52, 54, 59, 117, 
121, 123, 128 
48, 50, 52, 54, 59, 117, 121, 
123, 128 
 
T0524 3MWX 1SO0 73, 74, 177, 203, 230, 269, 
271, 283 
62, 63, 73, 74, 100, 101, 177, 
203, 230, 269, 271, 283, 285 
62, 63, 100, 101, 285 
T0526 3NRE 1NS0 56, 83, 148, 173, 200, 241, 
253 
43, 56, 77, 83, 148, 173, 200, 
241, 253 
43, 77 
T0529 3MWT  389, 390, 391, 533 389, 390, 391, 533  
T0539 2L0B  33, 36, 51, 53, 56, 59, 70, 
73 
33, 36, 51, 53, 56, 59, 70, 73  
T0547 3NZP 1TWI 84, 86, 87, 132, 231, 233, 
236, 273, 274, 320, 321, 
322, 323, 483, 519 
84, 86, 87, 132, 231, 233, 
236, 273, 274, 320, 321, 322, 
323, 452, 483, 484, 519 
452, 484 
T0548 3NNQ  58, 62, 95, 98 58, 62, 95, 98  
T0565 3NPF 3H41 191, 193, 202, 203, 262, 
263 
54, 80, 191, 193, 194, 202, 
203, 204, 221, 222, 262, 263 
54, 80, 194, 204, 221, 
222 
T0570 3NO3  30, 59, 61, 123, 156, 158, 
178, 222 
30, 59, 61, 123, 156, 158, 
178, 222 
 
T0582 3O14  58, 60, 64, 94 58, 60, 64, 94  
T0584 3NF2 1RQI 55, 58, 87, 104 55, 58, 87, 90, 91, 94, 103, 
104, 155, 183, 184, 221, 248 
90, 91, 94, 103, 155, 
183, 184, 221, 248 
T0585 3NE8  13, 28, 82, 84, 115 13, 28, 82, 84, 115  
T0591 3NRA  109, 110, 111, 135, 185, 
189, 217, 219, 251, 252, 
260, 283 
109, 110, 111, 135, 185, 189, 
217, 219, 251, 252, 260, 283 
 
T0597 3NIE  36, 37, 38, 39, 40, 41, 42, 
44, 57, 59, 73, 112, 114, 
117, 120, 158, 160, 163, 
174 
36, 37, 38, 39, 40, 41, 42, 44, 
57, 59, 73, 112, 114, 117, 
120, 158, 160, 163, 174 
 
T0599 3OS6 3HWO 213, 214, 215, 364, 377, 
381 
212, 213, 214, 215, 276, 304, 
328, 347, 348, 362, 364, 377, 
381 
212, 276, 304, 328, 347, 
348, 362 
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T0604 3NLC  113, 114, 116, 117, 118, 
137, 138, 166, 167, 170, 
171, 172, 174, 175, 177, 
178, 180, 241, 242, 243, 
272, 273, 274, 277, 280, 
352, 364, 365, 515, 516, 
523, 524, 527 
113, 114, 116, 117, 118, 137, 
138, 166, 167, 170, 171, 172, 
174, 175, 177, 178, 180, 241, 
242, 243, 272, 273, 274, 277, 
280, 352, 364, 365, 515, 516, 
523, 524, 527 
 
T0607 3PFE 2ZOF 96, 129, 163, 190, 442 96, 129, 162, 163, 165, 190, 
191, 205, 340, 410, 412, 413, 
414, 442 
162, 165, 191, 205, 340, 
410, 412, 413, 414 
T0609 3OS7 1Z45 67, 69, 108, 184, 288 67, 69, 80, 81, 108, 184, 245, 
286, 288, 300 
80, 81, 245, 286, 300 
T0613 3OBI 1C2T 177, 178, 225, 229, 230 173, 174, 175, 176, 177, 178, 
183, 192, 193, 194, 223, 225, 
226, 229, 230 
173, 174, 175, 176, 183, 
192, 193, 194, 223, 226 
T0615 3NQW 1VJ7 33, 36, 62, 63, 98, 102, 
123, 127, 139, 147 
26, 33, 36, 62, 63, 98, 102, 
123, 127, 128, 130, 131, 139, 
143, 147 
26, 128, 130, 131, 143 
T0622 3NKL 2VT2 10, 11, 12, 72 7, 9, 10, 11, 12, 33, 34, 35, 
38, 69, 70, 71, 72, 77, 81 
7, 9, 33, 34, 35, 38, 69, 
70, 71, 77, 81 
T0625 3ORU  126, 143, 207 126, 143, 207  
T0629 2XGF  73, 75, 105, 107, 119, 121, 
156, 158, 170, 172, 179, 
181, 188, 190 
73, 75, 105, 107, 119, 121, 
156, 158, 170, 172, 179, 181, 
188, 190 
 
T0632 3NWZ  76, 83, 109, 110, 117, 118, 
119, 120, 134, 136, 137, 
138, 139, 164, 166, 167 
76, 83, 109, 110, 117, 118, 
119, 120, 134, 136, 137, 138, 
139, 164, 166, 167 
 
T0635 3N1U  25, 27, 118 25, 27, 118  
T0636 3P1T 1GEX 22, 47, 145, 172, 197, 301, 
306, 313 
22, 47, 75, 76, 145, 169, 171, 
172, 194, 196, 197, 205, 206, 
225, 301, 306, 313 
75, 76, 169, 171, 194, 
196, 205, 206, 225 
T0641 3NYI  30, 65, 66, 67, 96, 97, 127, 
128, 129, 164, 166, 179, 
204, 241, 272, 275, 279, 
286 
30, 65, 66, 67, 96, 97, 127, 
128, 129, 164, 166, 179, 204, 
241, 272, 275, 279, 286 
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Table SII P-values computed by Wilcoxon Signed-Rank Test of all against all predictors. Significant 
differences between two groups are indicated by cells with white background. For clarity, only the 12 top 
performing predictors are shown, sorted by their overall performance. 
 
FN096 FN339 FN315 FN242 FN035 FN110 FN104 FN094 FN113 FN114 FN452 FN236 
FN096 - 0.11 0.01 0.16 0.14 0.00 0.01 0.00 0.00 0.01 0.00 0.00 
FN339 0.11 - 0.26 0.27 0.49 0.12 0.06 0.04 0.02 0.06 0.01 0.02 
FN315 0.01 0.26 - 0.76 0.23 0.79 0.39 0.10 0.05 0.18 0.16 0.09 
FN242 0.16 0.27 0.76 - 0.91 0.46 0.23 0.12 0.21 0.21 0.05 0.08 
FN035 0.14 0.49 0.23 0.91 - 0.92 0.39 0.10 0.10 0.18 0.18 0.17 
FN110 0.00 0.12 0.79 0.46 0.92 - 0.52 0.24 0.13 0.50 0.41 0.29 
FN104 0.01 0.06 0.39 0.23 0.39 0.52 - 0.78 0.71 0.37 0.73 0.50 
FN094 0.00 0.04 0.10 0.12 0.10 0.24 0.78 - 0.68 0.94 0.67 0.72 
FN113 0.00 0.02 0.05 0.21 0.10 0.13 0.71 0.68 - 0.87 0.95 0.64 
FN114 0.01 0.06 0.18 0.21 0.18 0.50 0.37 0.94 0.87 - 0.83 0.49 
FN452 0.00 0.01 0.16 0.05 0.18 0.41 0.73 0.67 0.95 0.83 - 0.87 
FN236 0.00 0.02 0.09 0.08 0.17 0.29 0.50 0.72 0.64 0.49 0.87 - 
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FM: Free-modeling category in CASP 
Abstract 
The identification of amino acid residues in proteins involved in binding small molecule ligands is 
an important step for their functional characterization, as the function of a protein often depends 
on specific interactions with other molecules. The accuracy of computational methods aiming to 
predict such binding residues was evaluated within the ―function prediction (prediction of binding 
sites, FN)‖ category of the critical assessment of protein structure prediction (CASP) experiment. 
In the last edition of the experiment (CASP10), 17 research groups participated in this category, 
and their predictions were evaluated on 13 prediction targets containing biologically relevant 
ligands. The results of this experiment indicate that several methods achieved an overall good 
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performance, showing the usefulness of such methods in predicting ligand binding residues. As 
in previous years, methods based on a homology transfer approach were dominating. In 
comparison to CASP9, a larger fraction of the top predictors are automated servers. However, 
due to the small number of targets and the characteristics of the prediction format, the 
differences observed among the first ten methods were not statistically significant and it was 
also not possible to analyze differences in accuracy for different ligand types or overall structure, 
difficulty. To overcome these limitations and to allow for a more detailed evaluation, in future 
editions of CASP, methods in the FN category will no longer be evaluated on the ―normal‖ CASP 
targets, but assessed continuously by CAMEO (continuous automated model evaluation) based 
on weekly pre-released sequences from the PDB. 
Introduction 
Proteins interact with a broad range of molecules to perform their function. While the majority of 
these interactions are unspecific and transient (e.g., with water molecules, ions and other 
solutes in the cell), others are very specific and essential for the function of the protein. Specific 
interactions can be stable, for example oligomeric proteins, or transient, for example in signaling 
networks or motor proteins. Binding partners of a protein are not limited to other proteins, but 
can include the whole range of other molecule types. Typical examples include complexes of 
enzymes with substrates and co-factors, receptors and ligands, antibodies and epitopes, 
transcription factors and cognate DNA, protein–RNA assemblies such as the ribosome, or 
ligands in a protein structure with a structural role. For the characterization of a new protein, 
information about ligands, cofactors and binding sites often provides crucial hints about its 
function. However, when determining the structure of a protein experimentally, ligands with 
medium to low binding affinities are often lost during the purification procedure, and the resulting 
structures often do not contain ligands. Additionally, in many cases neither the three-dimensional 
structure of the protein itself is known, nor the location and identity of possible ligands. To 
overcome these limitations, computational methods were established to predict from a protein's 
sequence its three-dimensional structure and possible ligand binding residues. Several 
computational approaches for predicting ligand binding sites have been developed, which differ 
with respect to the information they are based on: (1) only the sequence of the protein; (2) its 
structural properties; (3) both sequence and structure; (4) homologue proteins.[1-12]  
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The aim of the critical assessment of protein structure prediction (CASP) experiment is to assess 
the current state of the art of such methods, and to highlight bottlenecks and opportunities for 
further development. The accuracy of predictions of three-dimensional structures is assessed as 
part of the template-based (TBM) and free-modeling (FM) categories,[13-16] which includes the 
accuracy of binding site coordinates.[17, 18] Function prediction (FN) was introduced as a new 
category in CASP6.[19] In later editions, the definition of function predictions was specified as 
prediction of residues involved in binding relevant ligands.[20-22] Here, we describe the results 
of the assessment in the category ―prediction of binding sites (function prediction, FN)‖ of the 
CASP10 experiment. 
Materials and Methods 
Prediction format 
As in previous CASP experiments, the format for the predictions of binding residues for a given 
target protein consisted of a list of the amino-acid positions that were predicted to be in contact 
with a biologically relevant ligand. The CASP format did not include a confidence score, so that 
residues are classified in a binary way, either binding or not binding to any ligand. Predictors 
could optionally propose the name and the category of the compounds that could bind to these 
residues. One consequence of the prediction format is that it is not possible to correctly assess 
over-predictions; neither in case a target did not include any biologically relevant ligand, nor if a 
prediction indicated a binding site for a different ligand elsewhere in the target. 
Prediction targets 
All CASP10 target sequences were sent out as prediction targets in the FN category. [23] For 
the assessment, a subset of the target structures (coordinates available as of 2013-08-05) were 
selected, which contained at least one biologically relevant ligand. To define which ligands were 
considered as ―biologically relevant,‖ we used information coming from scientific literature, 
Swiss-Prot[24] annotations, sequence conservation of functionally important residues, and 
information from homologous structures. For the purpose of the assessment, covalently bound 
ligands in the reference structure were handled the same way as noncovalently bound ones. In 
case of oligomeric assemblies, the ―biological assembly units‖ as defined by the authors were 
used as reference target structures. 
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Binding site definition 
A binding site was defined by all protein residues in the target structure having at least one (non-
hydrogen) atom within a certain distance (di,j) to biologically relevant ligand atoms: 
𝑑𝑖 ,𝑗 = 𝑟𝑖 + 𝑟𝑗 + 𝑐 
where di,j is the distance between a residue atom i and a ligand atom j, ri and rj are the Van der 
Waals radii of the involved atoms, while c is a tolerance distance of 0.5 Å. In case the biological 
assembly of the experimental target structure represents a homo-oligomeric protein, or in case 
of NMR ensembles, residues were included in the binding site definition if they fulfilled the 
distance criterion in at least half of the reference chains. The binding site definitions used for the 
assessment are shown in Table 2. Analysis of ligand binding sites was implemented using 
OpenStructure (version 1.4). [25, 26] 
Binding site prediction evaluation 
According to the binding site definition in the experimental reference structure, predicted binding 
residues were classified as true positives (TP: correctly predicted binding site residue), true 
negatives (TN: correctly predicted nonbinding residue), false negatives (FN: incorrectly not 
predicted binding site residue), false positives (FP: incorrectly predicted non-binding residue). As 
in the previous CASP assessment [22]the evaluation of the quality of the binding site predictions 
was performed using the Matthews correlation coefficient (MCC): 
)()()()( FNTNFPTNFNTPFPTP
FNFPTNTP
MCC



 
MCC is a useful measure when the two classes (in our case binding and non-binding residues) 
are of very different sizes. MCC ranges from +1 (perfect prediction) to −1 (inverse prediction), 
where a MCC of 0 corresponds to random prediction. Raw scores and confusion matrices for all 
groups and all targets are provided in Supporting Information Table SI, SIV, and Figure S1. 
Finally, the MCCs were standardized by calculating their Z scores to allow the combination of 
scores for targets of different difficulty: 
𝑍𝑃 ,𝑇 =
𝑀𝐶𝐶𝑃,𝑇 − 𝑀𝐶𝐶𝑇        
𝜎𝑇
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where MCCP,T is the MCC of the predictor P for target T, 𝑀𝐶𝐶𝑇         is the mean MCC for the target T 
by all predictors P and σT is the standard deviation of the MCCs for the target T by all predictors 
P. The final ranking of the methods was based on the average value of the MCC across all 
targets. Cumulative confusion matrices are provided in Supporting Information. For 
completeness, we also assessed the accuracy of the predictions using the distance based 
method BDT[27] (see Supporting Information Table SIII). 
Statistical significance and robustness of the ranking 
To measure the statistical significance of the assessment results, we applied two-tailed 
Student's paired t test and Wilcoxon signed-rank test on the MCCs values for each target's 
predictions. Both tests were performed using the R statistical package (version 2.11.1) [28]. The 
robustness of the ranking based on MCC values was assessed by 100 rounds of random 
sampling using 70% of the targets. 
Results and discussion 
Prediction targets 
Although the CASP10 experiment had in total about 100 prediction targets, only very few of 
them had ligands which were classified as biologically relevant[23, 29]. In total, we identified 13 
targets with biologically relevant ligands, as listed in Tables 1 and 2. In eight targets, metal ions 
(Zn2+, Mg2+, Mn2+, Na+) are present, one contained an iron–sulfur cluster (SF4), one bound an 
adenine-mono-phosphate (AMP), one had a reduced Flavin mononucleotide (FNR), two had 
Flavin-adenine-dinucleotide (FAD) ligands, and one had LPP (N′-pyridoxyl-lysin-5′-
monophosphate) covalently bound at the dimer interface. It is worth emphasizing that the 
presence or absence of a ligand in a target structure depends on the experimental conditions, 
that is, the same binding site can be occupied by a ligand under one condition, and be empty or 
occupied by a different ligand under different conditions. Therefore, target structures without 
bound ligands can therefore not be considered as reference in the assessment. This issue is 
especially pronounced in prediction targets solved by high-throughput methods, where the 
experimental conditions often do not contain the biologically relevant ligands or cofactors. As a 
consequence, the number of targets that bind a relevant compound and that can be used for 
further prediction assessment in CASP10 is quite small. The following paragraph provides a 
short overview of the assessed targets. 
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Table 1 Targets with biologically relevant ligands used in the FN prediction assessment. 
Target PDB ID Ligand ID Type Interface 
T0652 4HG0 AMP Non-metal No 
T0657 2LUL ZN Metal No 
T0659 4ESN ZN (2) Metal No 
T0675 2LV2 ZN (2) Metal No 
T0686 4HQO MG Metal No 
T0696 n.a. NA Metal No 
T0697 n.a. LLP (2) Non-metal A-A 
T0706 n.a. MG (2) Metal A-A 
T0720 4IC1 MN(10)/SF4(10) Metal No 
T0721 4FK1 FAD (2) Non-metal No 
T0726 4FGM ZN Metal No 
T0737 3TD7 FAD Non-metal No 
T0744 2YMV FNR Non-metal No 
 
Table 2 Definition of ligand binding residues. 
Target Binding site (residue numbers) 
T0652 74, 79, 80, 99, 100, 101, 102, 103, 104, 165, 180, 182, 183 
T0657 121, 132, 133, 143 
T0659 43, 48, 63 
T0675 21, 24, 37, 42, 49, 52, 65, 70 
T0686 28, 30, 103 
T0696 18, 69, 104 
T0697 91, 150, 151, 152, 190, 243, 245, 247, 272, 274, 301, 303, 304, 351 
T0706 25, 27, 99, 101, 129, 130 
T0720 32, 34, 35, 62, 99, 113, 114, 115, 182, 188, 191, 194, 197, 200 
T0721 10, 12, 13, 14, 33, 34, 35, 36, 37, 38, 39, 42, 45, 46, 60, 78, 79, 80, 109, 110, 111, 
114, 126, 136, 235, 237, 268, 269, 277, 278, 281 
T0726 273, 277, 307 
T0737 37, 40, 41, 42, 44, 45, 49, 78, 83, 114, 117, 118, 120, 121, 123, 124, 128, 130, 135, 
138, 174, 237 
T0744 22, 23, 24, 26, 58, 61, 120, 121, 122, 124, 196, 214, 216, 270, 271, 272, 273, 314, 
316 
A residue in the target structure was defined as binding if it had at least one heavy atom of a biologically 
relevant ligand within 0.5 Å distance of the sum of the Van der Waals radii of the involved atoms. 
Target T0652 (PDB: 4HG0) 
The magnesium and cobalt efflux protein CorC contains two CBS (cystathionine-beta-synthase) 
domains, which bind an Adenosine monophosphate (AMP) [Fig. 1(A)], next to a transporter 
associated domain (CorC_HlyC) at the C terminus of the protein. CBS is a small intracellular 
module, mostly found in two or four copies next to a wide range of protein domains in bacteria, 
archaea, and eukaryotes [30] [31]. Pairs of CBS domains can bind adenosyl groups such as 
AMP, ATP or SAM, thus they could regulate the activity of the attached domains [32] and they 
may act as sensors of intracellular metabolites [33]. The CorC_HlyC transporter associated 
domain is found in a family of proteins of unknown function with CBS domain and also in CorC 
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involved in magnesium and cobalt efflux; it is hypothesized that it could modulate the transport of 
ion substrates. 
Target T0657 (PDB: 2LUL) 
The tyrosine-protein kinase Tec is composed by a PH (Pleckstrin homology) domain and a BTK 
(Btk-type zinc finger) domain that binds a Zn2+ cation [Fig. 7(A)]. The first occurs in many 
proteins involved in intracellular signaling or as part of the cytoskeleton [34], such as the 
beta/gamma subunits of heterotrimeric G proteins [35]. This domain has specificities for different 
membrane phosphoinositides phosphorylated at different sites within the inositol ring, so the 
function of PH-containing proteins is modulated by enzymes that dephosphorylate such rings. 
PH recruits proteins to different cellular compartments or it allows them to be involved in signal 
transduction pathways. The structure of this domain consists of two perpendicular antiparallel 
beta sheets followed by an amphiphatic helix; the loop between the beta strands has a very 
variable length. The BTK domain contains a conserved zinc-binding motif of one histidine and 
three cysteine residues, it is very close to the PH domain and it consists in a long loop held 
together by a zinc ion. 
Target T0659 (PDB: 4ESN) 
There are no sequence annotations on this target, a homo-dimer that binds a Zn2+ ion in both 
chains at the same position [Fig. 7(B)]. A DELTA-BLAST [36] search revealed a conserved 
domain of unknown function homologous to Listeria innocua Lin0431, a protein similar to the N-
utilization substance G (NusG) N terminal (NGN) insert (domain II, DII). Lin0431 has a similar 
structure and charged surface distribution to Aquifex aeolicus NusG DII, indicating a possible 
role in transcription or translation regulating functions. 
Target T0675 (PDB: 2LV2) 
The insulinoma-associated protein 1 contains two Zinc finger domains [Fig. 1(B)], which are 
stable structural motifs that bind DNA, RNA, protein, or lipid substrates [37] [38] [39] [40] [41]. 
Some types of this domain use zinc, others use iron or form salt-bridges to create the correct 
fold, which often does not change conformation upon binding the target. Zinc fingers are usually 
found in groups and they have different binding specificities depending on their amino acid 
sequence and on the overall structure of the protein containing them. The domains in this target 
are of the C2H2 type, where two conserved cysteines and histidines coordinate a zinc ion inside 
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of two short beta strands followed by an alpha helix; this ―finger‖ binds the major groove of the 
DNA. 
Target T0686 (PDB: 4HQO) 
The sporozoite surface protein 2 is the ectodomain of a thrombospondin repeat anonymous 
protein (TRAP), a mediator in the infection of mosquito and vertebrate cells and in the gliding 
motility of sporozoites, which is an important target of pre-erythrocytic malaria vaccines. TRAP 
passes through the plasma membrane and is attached to the actin cytoskeleton by aldolase [42]. 
This structure has a Von Willebrand factor type A (VWA) domain, binding a Mg2+ ion [Fig. 1(C)] 
which is additionally coordinated by three water molecules, and a thrombospondins (TSP) 
domain. The first is found in various plasma proteins, for example, complement factors or 
integrins, and is often involved in protein complexes which participate in various biological 
process (e.g., signal transduction, cell adhesion, pattern formation, and migration) [43]; it 
contains a metal ion site at the surface that could represent a general metal ion-dependent 
adhesion site (MIDAS) for binding protein ligands [44]. This site binds magnesium in the I-
domain of integrins CD11b [44] and manganese in CD11a [45] by slightly different coordination 
of the same conserved residues [45]. TSP is a multimeric multidomain glycoprotein functioning 
in the extracellular matrix and it regulates cell interactions. 
Target T0696 (PDB: n.a.) 
A DELTA-BLAST search relates this target with a conserved domain superfamily called 
―Glyoxalase/fosfomycin resistance/dioxygenase domain,‖ which is found in a variety of 
structurally related, but functionally diverse metallo-proteins, including glyoxalase I, type I 
extradiol dioxygenases and some antibiotic resistance proteins. They use different metal cations 
for their catalytic activity (e.g., Fe2+, Mn2+, Zn2+, Ni2+, or Mg2+). In this target the binding site is 
occupied by a Na+ [Fig. 1(D)], which substitutes one of mentioned metal ions. 
Target T0697 (PDB: n.a.) 
It belongs to the pyridoxal phosphate (PLP)-dependent decarboxylase family (EC number 4.1.1) 
group 2, which includes glutamate, histidine, tyrosine, and aromatic-l-amino-acid 
decarboxylases. This family is involved in the biosynthesis of amino acids, their derived 
metabolites, amino sugars and in the synthesis or catabolism of neurotransmitters. The PLP 
cofactor [Fig. 1(E)] forms a Schiff base with a conserved lysine in the active site, which is 
55 
 
temporarily displaced by the substrate; the resulting aldimine is the common central intermediate 
for PLP-catalyzed reactions[46]. 
Target T0706 (PDB: n.a.) 
A DELTA-BLAST search indicates that the target belongs to the Von Willebrand factor type A 
domain family, which contains a metal ion-dependent adhesion site (MIDAS) for binding protein 
ligands (for details, see also target T0686). In this target, a Mg2+ ion is bound to the adhesion 
site [Fig. 1(F)]. 
Target T0720 (PDB: 4IC1) 
The CRISPR-associated exonuclease Cas4 (EC = 3.1.-.-) protein is involved in the mobile 
genetic elements immunity of the CRISPR (clustered regularly interspaced short palindromic 
repeat) system in most bacteria and archea [47]. Short DNA sequences from viruses, the 
―spacers,‖ are flanked by CRISPR repeats in the host genome and transcribed into CRISPR 
RNAs (crRNAs), which are used by Cas (CRISPR-associated) proteins to recognize and 
degrade viral cognate sequences. This target in particular belongs to the Cas4 family of proteins, 
which resembles the RecB family [48] and contains a cysteine-rich motif similar to the AddB 
family [49]. It is a 5' ssDNA metal-dependent (magnesium or manganese) exonuclease that 
needs an iron–sulfur cluster for structural stability [Fig. 1(G,H)] [50]. 
Target T0721 (PDB: 4FK1) 
The putative Thioredoxin reductase TrxB contains a FAD-dependent pyridine nucleotide-
disulfide oxidoreductase domain with a FAD bound [Fig. 1(I)]. 
Target T0726 (PDB: 4FGM) 
It contains an M61 glycyl aminopeptidase and a PDZ domain. Metalloproteases containing the 
first domain bind a divalent cation, through His, Glu, Asp, or Lys amino acids, that activates the 
water molecule; usually a zinc ion is bound by three residues which often can be described by 
an HEXXH motif (X can be any amino acid) [51]. The target binds a Zn2+ ion with the motif's 
histidines and a different glutamate [Fig. 1(J)]. The second domain is found in eukaryotes [52] 
and it binds the target protein by extending its beta-sheet with a strand from the partner C-
terminus, so acting as a bridge between transmembrane proteins and the cytoskeleton in 
signaling pathways [53]. 
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Target T0737 (PDB: 3TD7) 
It is the probable FAD-linked sulfhydryl oxidase R596 from the Acanthamoeba polyphaga 
mimivirus. Its sequence contains a ERV/ALR sulfydryl oxidase domain which catalyzes disulfide 
bond formations. This module has a CXXC motif next to a FAD cofactor [in Fig. 1(K)] which is 
used to transfer electrons from the thiol substrates to the (non-thiol) acceptor. A structure with 
bound FAD (PDB code: 3GWN) was available at the time of prediction for this target. 
Target T0744 (PDB: 2YMV) 
It is a homologue of Mycobacterium tuberculosis Acg (Rv2032) in the reduced form from 
Mycobacterium smegmatis. The proteins in the Acg family are monomers that resemble the 
nitroreductase homodimer fold, with a single flavin mononucleotide binding site [Fig. 1(L)] closed 
by a lid, instead of two open binding sites as in homodimeric nitroreductases. The structure and 
the lack of reduction by NADPH suggest that this proteins has lost the nitroreductase function 
and instead they may act as inhibitor of another nitroreductase by storing the flavin cofactor 
during the dormancy state of the bacteria [54]. 
 
Figure 1 Binding sites and ligands of the assessed targets. Biologically relevant ligands are colored in 
green and the residues included in the binding site are colored in blue. Targets and ligands included here: 
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(A) T0652: AMP, (B) T0675: ZN, (C) T0686: MG, (D) T0696: NA, (E) T0697: LLP, (F) T0706: MG, (G,H) 
T0720: SF4 and MN, (I) T0721: FAD, (J) T0726: ZN, (K) T0737: FAD, (L) T0744: FNR. Targets T0657 
and T0659 are in Figure 7. 
Overall performance 
As in previous years, the evaluation of the binding site prediction accuracy was based on the 
Matthew Correlation Coefficient. A total of 1817 submissions by 19 groups for the FN category 
were received by the Prediction Center. In CASP10 only 13 target proteins contained relevant 
ligands, that is, only a small subset of all submissions could be used for the assessment (Fig. 2). 
Of the 17 groups4 in the assessment, most of them submitted predictions for all 13 targets. 
Missing predictions were assigned a MCC score of zero, corresponding to a random prediction. 
Figure 3 shows a box plot representing the MCC distributions for each target, which gives a first 
estimate of the prediction difficulty. On most targets the predictors achieved on average a good 
performance around an MCC of 0.6, except in three cases, where in two (T0657 and T0659) the 
median scores were around zero and in one (T0720) was around 0.2.  
 
Figure 2. Number of predictions per group. Because only a small number of all CASP10 targets contained 
relevant ligands, only a few predictions could be used for the assessment (dark blue and dark green), 
while the majority of the predictions could not be evaluated (blue and green). 
                                               
4
 Predictions by two groups were excluded from the assessment by the CASP organizers. 
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Figure 3 Target difficulty. Distribution of the predictor's MCC for each target shown as Box plot (1st 
quartile, median and 3rd quartile), indicating the difficulty in the prediction of the various binding sites. 
For comparison of the method's overall performance, groups were ranked according to the 
average value of their MCCs normalized on all prediction targets (Fig. 4; Supporting Information 
Table SI). Within the first ten groups, there were more ―servers‖ at CASP10 than in CASP9, six 
instead of two, with an average MCC of 0.62. Their performance was indistinguishable from the 
―human‖ predictors, which is an improvement with respect to the results obtained in CASP9. The 
main differences between ―human‖ and ―server‖ methods is that the former could access human-
only readable data (e.g., literature or databases) to identify relevant ligands, and have access to 
the pool of 3D structure predictions by servers due to the late submission deadline. While there 
was only a difference of 0.15 between the top ten groups based on average MCC, group FN119 
(Firestar [10]) and FN326 (SP-ALIGN [11]) achieved the best scores of 0.715 and 0.707, 
respectively. These two methods had an overall different behaviour: Firestar was one of the two 
predictors, together with HHPredA, with the highest number of top scores; it had the best MCC 
in three targets (T0696, T0726, T0744) while SP-ALIGN only for T0659, which was the most 
difficult target. 
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Figure 4 Groups ranking by MCC. The predictors are ranked in decreasing order by the average value of 
the MCC, calculated on all the evaluated targets. Human predictors are shown in blue and server 
predictors in yellow. 
We also evaluated the predictors‘ performances based on the distance-based BDT measure 
(Supporting Information Table SIII), which gave a ranking very similar to the MCC averages that 
was within deviations expected from the robustness test described below. To better understand 
to which extend these methods were useful in practice, we compared their performance with a 
baseline predictor that inferred the target's binding sites using the first ten templates with ligands 
found by DELTA-BLAST and collecting all the residues in contact with them. The resulting 
average MCC was 0.339, which is only half of the performance obtained by the top predictors, 
and only two methods in the experiment performed worse than this baseline. This result 
indicates that most of the methods assessed in CASP10 give advantages in the ligand binding 
site prediction compared to a naïve homology search approach and could positively support the 
characterization of a protein's function. 
Assessment robustness 
Because the number of prediction targets was extremely small, we assessed the robustness of 
the ranking by calculating MCC distributions with 100 cycles of random sampling using 70% of 
the targets (Fig. 5). Although, the median values confirm the order of the top groups ranked by 
MCC, the rank spread is rather large and fluctuations by 10 positions are not unusual, that is, the 
ranking is strongly influenced by the composition of the data set and does therefore not 
necessarily correctly reflect the differences in prediction accuracy of the individual methods. 
When calculating the statistical significance of the overall ranking by applying Student's t test 
(data not shown) and Wilcoxon signed-rank test (Supporting Information Table SII), the results 
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indicated that the ranking was not robust and the differences between the top ten groups were 
not statistically significant. Both results are not surprising, considering the fact that the 
assessment had to be based on a very small number of target structures. 
 
Figure 5 Groups ranking robustness. Methods were ranked using the median value of the MCC 
distributions after 100 cycles of random sampling using 70% of the targets. Bars indicate best, median and 
worst ranking for each group. 
Top predictors’ methods are based on homology transfer 
Let's take a closer look at the groups ranked highest by MCC: Firestar (FN119), SP-ALIGN 
(FN326), CNIO (FN475), and Cofactor_human (FN208); the first two were registered to CASP10 
as ―server,‖ while the last two as ―human‖ predictor groups. Firestar [10] bases its predictions on 
homology transfer of functionally important residues, found by local evolutionary sequence 
conservation; SP-ALIGN, an update to FINDSITE [11], is a threading based method to detect 
ligand binding sites by the employment of remote template identification and superimposition, 
structure-pocket alignment and binding site clustering guided by the template ligands; CNIO 
combines predictions from Firestar and 3DLigandSite [12], which clusters superimposed ligands 
from homologous structures to identify the binding residues; Cofactor_human requires human 
assistance to validate the binding residues found by the Cofactor algorithm [55], which employs 
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a local superimposition of conserved residues taken from the target's templates. The common 
theme among these methods is that they are all based on the analysis of the ligands bound to 
homologous structures. Firestar and CNIO use FireDB [56], Cofactor employs structures from 
BioLip [57], while SP-ALIGN uses an ad hoc template library. As a consequence, the 
performance of these methods is tied to the availability of annotated protein structures and the 
ability of finding homologue templates. Nevertheless, it has to be noted that the protocol to 
transfer the information on binding residues is different among those methods. 
In recent years, homology based methods for structure prediction have started to reach a 
substantial coverage for proteins of interest: today some form of structural information—either 
experimental or computational—is available for the majority of amino acids encoded by common 
model organism genomes[58]. For almost all known protein-protein interactions for which the 
individual components are structurally characterized, structures of complexes can be identified in 
the PDB which can be used for template-based prediction approaches[59-61]. The overall good 
performances of methods such as Firestar and SP-ALIGN in CASP10, and their ability to identify 
ligand binding sites in different families of proteins in the absence of close homologue targets 
indicates that the field of ligand binding site prediction shows a similar trend. 
It should be noted that in previous editions of CASP, almost all FN targets were classified as 
―template based modeling‖ (TBM) and only very few as ―free modeling‖ (FM). In this round of 
CASP10, none of the relevant ligand binding sites were located in FM targets. Although target 
T0737 is classified as ―free modeling,‖ the part of the protein to which the ligand FAD is bound 
has experimental structure information (Fig. 6). This directly implies that the CASP assessment 
is mainly suitable to evaluate methods based on homology transfer to predict binding residues, 
but unable to measure the performance on harder targets, for which template structure 
information is not a useful source of information. 
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Figure 6 FAD binding site in target T0737. Residues 176–292 (D1, blue) have been classified as ―free 
modeling.‖ However, the N-terminal domain (grey) where the ligand FAD is bound, is covered by 
experimental structures. (Image generated with OpenStructure). 
Prediction examples 
Two targets, T0657 and T0659, appeared to be most challenging as predictors obtained on 
average the lowest scores. The first (PDB: 2LUL) was a solution NMR structure of the PH 
domain from the ―Tyrosine-protein kinase Tec,‖ bound to a Zn2+ ion in a Btk-type zinc finger [Fig. 
7(A)]. On a first view, this appears to be a simple template-based modeling target, since at least 
one template with the correct ion bound (e.g., PDB:1B55) is easily detectable with BLAST. 
However, the median MCC achieved for this target was −0.05, where the best predictor 
(―Binding_Kihara‖, FN231) achieved an MMC of 1 (Supporting Information Table SI). Other 
predictors achieved a lower MCC of about 0.3, mainly because they predicted more binding 
residues than were present in the reference structure, some of which have been assigned to 
other ligands than Zinc as indicated in the comments field. This example illustrates one of the 
limitations of the current binary prediction format. 
The second target, T0659 (PDB: 4ESN), was a crystal structure of a hypothetical protein that 
bound a Zn2+ ion by three conserved Cysteines [Fig. 7(B)]. The median MCC was zero, while the 
best score, an MCC of 0.69 (Supporting Information Table SI), was obtained for a prediction by 
SP-ALIGN (FN326), which is shown in Figure 7(B). Easily detectable homologous structures of 
this protein did not contain any ligand, which explains the overall weak performance on this 
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target. Interestingly, SP-ALIGN predicted an iron ion bound at this position; potentially, this could 
be due to the employment of its threading based method that detected a remote homologue 
bound to that ion. 
 
Figure 7 Binding site prediction examples. Residues are colored as ―correctly predicted‖ (true positive, 
green) and ―wrongly predicted‖ (false positive, violet). (A) The Zn
2+
 binding site in a Btk-type zinc finger in 
the PH domain from the Tyrosine-protein kinase Tec (T0657) is formed by His 121, Cys 132, Cys 133, and 
Cys 143. Coloring according to prediction by group ―Binding_Kihara‖ (FN231). (B) Structure of a 
hypothetical protein T0659 with a Zn
2+
 ion bound by three conserved Cysteine residues (Cys 43,48,63). 
Coloring according to predictions by group ―SP-ALIGN‖ (FN326). 
Conclusions 
Predicting a protein's binding site is an important step toward understanding its function, and has 
implications for gene product characterization, drug design and enzyme engineering. The 13 
targets evaluated in the assessment include proteins with interesting functions. For example 
T0686, which contains a metal ion-dependent adhesion site (MIDAS) which mediates the 
invasion of vertebrate cells by malaria Sporozoites; or T0720—a CRISPR-associated (Cas) 
protein involved in the genetic mobile elements defense and it contains a catalytic magnesium 
ion plus a structural iron–sulfur cluster. As in previous years, homology transfer approaches, in 
which the target binding residues are inferred from homologous proteins, have scored best with 
an average MCC of 0.71. 
As in previous rounds of the CASP experiment, only a very limited number of targets with 
biologically relevant ligands (13 out of 97 targets) were available. Consequently, the assessment 
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did not lead to a stable ranking of the participating methods, and it was not possible to 
differentiate methods by their performance on different types of targets or ligands. Another 
limitation originates from the current binary prediction format (―binding‖ or ―not binding‖), which 
does not include any information on the type of compounds or a level of confidence for the 
prediction. For a more detailed discussion, see assessment of ligand binding predictions in 
CASP9 [22]. 
During the CASP10 predictors meeting in Gaeta, it was recognized that the current procedure is 
not appropriate to assess the state of the art in ligand binding site predictions, and therefore 
does not stimulate the development of new approaches. To overcome these limitations, the 
following improvements should be implemented: (a) Binary predictions should be replaced by 
predicting continuous probability values. (b) The prediction format should include the 
specification of ligand type/ligand identity. (c) The number of prediction targets, specifically those 
without trivial templates, needs to be increased substantially. 
Based on these considerations, prediction methods in the FN category in future editions of 
CASP will no longer be evaluated based on the regular set of CASP target proteins. Instead, 
ligand binding site prediction servers will be evaluated continuously using an automated system 
called continuous automated model evaluation (CAMEO, http://www.cameo3d.org/), which is 
based on weekly pre-released sequences from the PDB. Continuous evaluation allows 
developers to constantly monitor the performance of new developments. Thanks to the larger 
number of targets, continuous evaluation also provides statistically robust assessment of ligand 
binding site predictions and allows for a more detailed assessment of methods, for example, by 
ligand type or target difficulty. We hope that these new developments will stimulate new methods 
and approaches in this important area of structural bioinformatics. 
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Supporting information 
Table S1 Raw scores. Raw scores for each group that provided a prediction for a FN target. TP: True 
Positive, FP: False Positive, FN: False Negative, TN: True Negative, MCC: Matthews Correlation 
Coefficient. 
Target Group TP FP FN TN MCC MCC Z-score 
T0652 CONPRED-UCL 11 7 2 212 0.7 0.010 
T0652 FIRESTAR 12 4 1 215 0.821 0.447 
T0652 3DLIGANDSITE2 12 4 1 215 0.821 0.447 
T0652 COFACTOR_HUMAN 11 4 2 215 0.774 0.277 
T0652 ATOME2_CBS 13 5 0 214 0.84 0.516 
T0652 COFACTOR 11 4 2 215 0.774 0.277 
T0652 BINDING_KIHARA 8 6 5 213 0.568 -0.468 
T0652 SEOK-SERVER 11 0 2 219 0.916 0.791 
T0652 INTFOLD2 12 3 1 216 0.85 0.552 
T0652 MCGUFFIN 12 3 1 216 0.85 0.552 
T0652 SP-ALIGN 11 3 2 216 0.804 0.386 
T0652 HHPREDA 12 4 1 215 0.821 0.447 
T0652 CHUO-BINDING-SITES 9 4 4 215 0.674 -0.084 
T0652 SEOK 11 0 2 219 0.916 0.791 
T0652 CNIO 12 8 1 211 0.726 0.104 
T0657 CONPRED-UCL 0 17 4 133 -0.058 -0.744 
T0657 FNGUSHAK 0 13 4 137 -0.05 -0.721 
T0657 FIRESTAR 4 16 0 134 0.423 0.636 
T0657 3DLIGANDSITE2 0 9 4 141 -0.041 -0.696 
T0657 COFACTOR_HUMAN 4 15 0 135 0.435 0.670 
T0657 ATOME2_CBS 0 14 4 136 -0.052 -0.727 
T0657 COFACTOR 4 15 0 135 0.435 0.670 
T0657 BINDING_KIHARA 4 0 0 150 1 2.292 
T0657 3DLIGANDSITE 0 9 4 141 -0.041 -0.696 
T0657 SEOK-SERVER 0 7 4 143 -0.036 -0.681 
T0657 INTFOLD2 0 9 4 141 -0.041 -0.696 
T0657 MCGUFFIN 0 9 4 141 -0.041 -0.696 
T0657 SP-ALIGN 4 1 0 149 0.891 1.979 
T0657 HHPREDA 0 15 4 135 -0.054 -0.733 
T0657 CHUO-BINDING-SITES 4 44 0 106 0.243 0.119 
T0657 SEOK 0 8 4 142 -0.038 -0.687 
T0657 CNIO 4 14 0 136 0.449 0.710 
T0659 CONPRED-UCL 0 0 3 71 0 -0.383 
T0659 FNGUSHAK 1 6 2 65 0.168 0.364 
T0659 FIRESTAR 0 0 3 71 0 -0.383 
T0659 COFACTOR 0 4 3 67 -0.049 -0.601 
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T0659 BINDING_KIHARA 0 0 3 71 0 -0.383 
T0659 INTFOLD2 0 0 3 71 0 -0.383 
T0659 MCGUFFIN 0 0 3 71 0 -0.383 
T0659 SP-ALIGN 3 3 0 68 0.692 2.693 
T0659 HHPREDA 2 1 1 70 0.653 2.520 
T0659 CHUO-BINDING-SITES 0 0 3 71 0 -0.383 
T0675 CONPRED-UCL 6 4 2 63 0.627 0.169 
T0675 FNGUSHAK 3 1 5 66 0.495 -0.179 
T0675 FIRESTAR 7 0 1 67 0.929 0.964 
T0675 COFACTOR_HUMAN 8 0 0 67 1 1.151 
T0675 ATOME2_CBS 0 0 8 67 0 -1.482 
T0675 COFACTOR 5 6 3 61 0.467 -0.252 
T0675 BINDING_KIHARA 8 1 0 66 0.936 0.982 
T0675 SEOK-SERVER 6 1 2 66 0.78 0.572 
T0675 INTFOLD2 4 0 4 67 0.687 0.327 
T0675 MCGUFFIN 4 0 4 67 0.687 0.327 
T0675 SP-ALIGN 4 0 4 67 0.687 0.327 
T0675 CHUO-BINDING-SITES 7 29 1 38 0.273 -0.763 
T0675 SEOK 8 0 0 67 1 1.151 
T0675 CNIO 8 0 0 67 1 1.151 
T0686 CONPRED-UCL 3 1 0 250 0.864 1.032 
T0686 FNGUSHAK 3 6 0 245 0.57 -0.111 
T0686 FIRESTAR 3 2 0 249 0.772 0.674 
T0686 3DLIGANDSITE2 2 1 1 250 0.663 0.250 
T0686 COFACTOR_HUMAN 3 2 0 249 0.772 0.674 
T0686 ATOME2_CBS 0 0 3 251 0 -2.328 
T0686 COFACTOR 3 14 0 237 0.408 -0.741 
T0686 BINDING_KIHARA 1 5 2 246 0.223 -1.461 
T0686 3DLIGANDSITE 3 1 0 250 0.864 1.032 
T0686 SEOK-SERVER 2 2 1 249 0.572 -0.104 
T0686 INTFOLD2 3 2 0 249 0.772 0.674 
T0686 MCGUFFIN 3 1 0 250 0.864 1.032 
T0686 SP-ALIGN 2 1 1 250 0.663 0.250 
T0686 HHPREDA 3 4 0 247 0.649 0.196 
T0686 CHUO-BINDING-SITES 3 67 0 184 0.177 -1.640 
T0686 SEOK 3 2 0 249 0.772 0.674 
T0686 CNIO 2 2 1 249 0.572 -0.104 
T0696 CONPRED-UCL 3 6 0 91 0.559 0.099 
T0696 FNGUSHAK 3 3 0 94 0.696 0.549 
T0696 FIRESTAR 3 0 0 97 1 1.547 
T0696 COFACTOR_HUMAN 2 1 1 96 0.656 0.418 
T0696 ATOME2_CBS 0 0 3 97 0 -1.736 
T0696 COFACTOR 2 1 1 96 0.656 0.418 
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T0696 BINDING_KIHARA 3 0 0 97 1 1.547 
T0696 3DLIGANDSITE 1 2 2 95 0.313 -0.708 
T0696 SEOK-SERVER 2 1 1 96 0.656 0.418 
T0696 INTFOLD2 1 2 2 95 0.313 -0.708 
T0696 MCGUFFIN 1 2 2 95 0.313 -0.708 
T0696 SP-ALIGN 2 0 1 97 0.812 0.930 
T0696 HHPREDA 3 11 0 86 0.436 -0.304 
T0696 CHUO-BINDING-SITES 3 22 0 75 0.305 -0.734 
T0696 SEOK 2 5 1 92 0.411 -0.386 
T0696 CNIO 3 1 0 96 0.862 1.094 
T0697 CONPRED-UCL 1 2 13 446 0.143 -2.477 
T0697 FNGUSHAK 13 4 1 444 0.837 0.374 
T0697 FIRESTAR 12 3 2 445 0.823 0.316 
T0697 3DLIGANDSITE2 12 3 2 445 0.823 0.316 
T0697 COFACTOR_HUMAN 13 1 1 447 0.926 0.739 
T0697 ATOME2_CBS 12 1 2 447 0.886 0.575 
T0697 COFACTOR 13 1 1 447 0.926 0.739 
T0697 BINDING_KIHARA 2 6 12 442 0.17 -2.366 
T0697 3DLIGANDSITE 12 3 2 445 0.823 0.316 
T0697 SEOK-SERVER 11 0 3 448 0.883 0.562 
T0697 INTFOLD2 12 2 2 446 0.853 0.439 
T0697 MCGUFFIN 12 2 2 446 0.853 0.439 
T0697 SP-ALIGN 12 4 2 444 0.795 0.201 
T0697 HHPREDA 11 1 3 447 0.844 0.402 
T0697 CHUO-BINDING-SITES 14 44 0 404 0.467 -1.146 
T0697 SEOK 10 0 4 448 0.841 0.390 
T0697 CNIO 13 6 1 442 0.79 0.180 
T0706 CONPRED-UCL 4 1 2 197 0.723 0.592 
T0706 FNGUSHAK 3 1 3 197 0.603 0.222 
T0706 FIRESTAR 4 1 2 197 0.723 0.592 
T0706 COFACTOR_HUMAN 5 3 1 195 0.712 0.558 
T0706 ATOME2_CBS 0 0 6 198 0 -1.637 
T0706 COFACTOR 4 0 2 198 0.812 0.866 
T0706 BINDING_KIHARA 0 3 6 195 -0.021 -1.702 
T0706 SEOK-SERVER 4 1 2 197 0.723 0.592 
T0706 INTFOLD2 4 2 2 196 0.657 0.389 
T0706 MCGUFFIN 4 2 2 196 0.657 0.389 
T0706 SP-ALIGN 4 0 2 198 0.812 0.866 
T0706 HHPREDA 5 1 1 197 0.828 0.916 
T0706 CHUO-BINDING-SITES 5 23 1 175 0.352 -0.552 
T0706 SEOK 4 1 2 197 0.723 0.592 
T0706 CNIO 4 1 2 197 0.723 0.592 
T0720 CONPRED-UCL 0 0 16 186 0 -1.371 
68 
 
T0720 FNGUSHAK 4 7 12 179 0.253 -0.184 
T0720 FIRESTAR 4 0 12 186 0.485 0.904 
T0720 3DLIGANDSITE2 2 2 14 184 0.221 -0.334 
T0720 COFACTOR_HUMAN 2 2 14 184 0.221 -0.334 
T0720 ATOME2_CBS 0 0 16 186 0 -1.371 
T0720 COFACTOR 2 2 14 184 0.221 -0.334 
T0720 BINDING_KIHARA 2 1 14 185 0.267 -0.118 
T0720 SEOK-SERVER 2 2 14 184 0.221 -0.334 
T0720 INTFOLD2 3 5 13 181 0.222 -0.330 
T0720 MCGUFFIN 3 3 13 183 0.273 -0.090 
T0720 SP-ALIGN 5 0 11 186 0.543 1.177 
T0720 HHPREDA 9 1 7 185 0.694 1.885 
T0720 CHUO-BINDING-SITES 5 13 11 173 0.23 -0.292 
T0720 SEOK 4 1 12 185 0.425 0.623 
T0720 CNIO 8 0 8 186 0.692 1.876 
T0721 CONPRED-UCL 20 11 11 257 0.604 -0.894 
T0721 FNGUSHAK 26 7 5 261 0.791 0.679 
T0721 FIRESTAR 23 7 8 261 0.726 0.132 
T0721 3DLIGANDSITE2 26 16 5 252 0.683 -0.230 
T0721 COFACTOR_HUMAN 23 5 8 263 0.757 0.393 
T0721 ATOME2_CBS 22 8 9 260 0.69 -0.171 
T0721 COFACTOR 23 5 8 263 0.757 0.393 
T0721 BINDING_KIHARA 6 2 25 266 0.352 -3.015 
T0721 3DLIGANDSITE 29 16 2 252 0.747 0.309 
T0721 SEOK-SERVER 21 7 10 261 0.681 -0.246 
T0721 INTFOLD2 25 4 6 264 0.815 0.881 
T0721 MCGUFFIN 21 3 10 265 0.747 0.309 
T0721 SP-ALIGN 28 11 3 257 0.78 0.587 
T0721 HHPREDA 29 5 2 263 0.88 1.428 
T0721 CHUO-BINDING-SITES 31 46 0 222 0.577 -1.122 
T0721 SEOK 22 8 9 260 0.69 -0.171 
T0721 CNIO 27 8 4 260 0.798 0.738 
T0726 CONPRED-UCL 3 5 0 579 0.61 0.089 
T0726 FNGUSHAK 3 10 0 574 0.476 -0.389 
T0726 FIRESTAR 3 0 0 584 1 1.479 
T0726 3DLIGANDSITE2 3 5 0 579 0.61 0.089 
T0726 COFACTOR_HUMAN 3 7 0 577 0.544 -0.146 
T0726 ATOME2_CBS 3 21 0 563 0.347 -0.848 
T0726 COFACTOR 3 7 0 577 0.544 -0.146 
T0726 BINDING_KIHARA 0 3 3 581 -0.005 -2.103 
T0726 3DLIGANDSITE 3 3 0 581 0.705 0.428 
T0726 SEOK-SERVER 3 0 0 584 1 1.479 
T0726 INTFOLD2 3 2 0 582 0.773 0.670 
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T0726 MCGUFFIN 3 0 0 584 1 1.479 
T0726 SP-ALIGN 3 18 0 566 0.372 -0.759 
T0726 HHPREDA 3 8 0 576 0.519 -0.235 
T0726 CHUO-BINDING-SITES 3 97 0 487 0.158 -1.522 
T0726 SEOK 3 2 0 582 0.773 0.670 
T0726 CNIO 3 8 0 576 0.519 -0.235 
T0737 CONPRED-UCL 18 14 4 217 0.642 -0.803 
T0737 FNGUSHAK 18 9 4 222 0.711 -0.251 
T0737 FIRESTAR 16 3 6 228 0.764 0.173 
T0737 3DLIGANDSITE2 17 4 5 227 0.772 0.237 
T0737 COFACTOR_HUMAN 17 4 5 227 0.772 0.237 
T0737 ATOME2_CBS 20 10 2 221 0.755 0.101 
T0737 COFACTOR 17 4 5 227 0.772 0.237 
T0737 BINDING_KIHARA 5 0 17 231 0.46 -2.260 
T0737 3DLIGANDSITE 20 2 2 229 0.9 1.262 
T0737 SEOK-SERVER 16 1 6 230 0.814 0.573 
T0737 INTFOLD2 18 2 4 229 0.845 0.822 
T0737 MCGUFFIN 18 1 4 230 0.87 1.022 
T0737 SP-ALIGN 16 7 6 224 0.683 -0.475 
T0737 HHPREDA 16 4 6 227 0.741 -0.011 
T0737 CHUO-BINDING-SITES 19 40 3 191 0.46 -2.260 
T0737 SEOK 16 1 6 230 0.814 0.573 
T0737 CNIO 18 2 4 229 0.845 0.822 
T0744 CONPRED-UCL 13 15 6 293 0.531 -0.287 
T0744 FNGUSHAK 16 6 3 302 0.768 1.213 
T0744 FIRESTAR 15 2 4 306 0.825 1.573 
T0744 3DLIGANDSITE2 16 9 3 299 0.716 0.884 
T0744 COFACTOR_HUMAN 12 7 7 301 0.609 0.207 
T0744 ATOME2_CBS 9 10 10 298 0.441 -0.856 
T0744 COFACTOR 12 7 7 301 0.609 0.207 
T0744 BINDING_KIHARA 3 2 16 306 0.289 -1.818 
T0744 3DLIGANDSITE 10 3 9 305 0.619 0.270 
T0744 SEOK-SERVER 7 13 12 295 0.318 -1.635 
T0744 INTFOLD2 10 2 9 306 0.647 0.447 
T0744 MCGUFFIN 9 1 10 307 0.639 0.396 
T0744 SP-ALIGN 16 13 3 295 0.658 0.517 
T0744 HHPREDA 9 8 10 300 0.472 -0.660 
T0744 CHUO-BINDING-SITES 14 38 5 270 0.392 -1.166 
T0744 SEOK 9 7 10 301 0.489 -0.553 
T0744 CNIO 15 4 4 304 0.776 1.263 
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Figure S1: Cumulative confusion matrices for the top 6 groups as pie charts.  
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4. CAMEO Ligand binding 
Introduction 
The recent developments of high-throughput sequencing techniques and the setup of structural 
genomic initiatives have increased the number of available protein sequences and structures, 
however mostly without functional characterization. To investigate the role of these proteins, 
several computational methods have been developed (for some examples, see [1-3]); in 
particular, the annotation of protein binding sites and of their ligands provided a fundamental 
step in the discovery of protein functional details at the molecular level. This piece of information 
is, in fact, essential for important applications such as drug design and enzyme engineering. For 
this reason, computational methods for ligand binding prediction were assessed each two years 
starting from the 7th edition of CASP in 2007 [4]. These evaluations provided a valuable tool for 
comparing the performances of different methods, but two major limitations in the assessment 
emerged during the last CASP editions (see [5] in chapter 2 and [6] in chapter 3). Essentially, 
these drawbacks consisted in the low number of target structures bound to biologically relevant 
ligands and the classification of the target residues in either ―binding‖ or ―non-binding‖, without 
taking into account the affinities for different potential ligands.  
The Continuous Automated Model EvaluatiOn (CAMEO) Ligand Binding framework was 
developed to solve these issues and to provide a constant assessment of the state-of-the-art 
prediction methods. More in detail, participants are evaluated on the weekly PDB releases, in 
order to assess their server performances, in the long term, on a larger number of targets than in 
CASP. Additionally, the binary classification has been substituted by a continuous score that 
reflects the binding likelihood. Finally, the predictions are evaluated in a separate way for each 
chemical type of ligand. 
Methods 
Targets 
To each registered server, every week CAMEO sends a group of pre-released PDB sequences 
with a minimum length of 30 amino acids. All the received predictions are collected by CAMEO 
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until the PDB publishes the structures of the pre-released sequences. Then, the Ligand Binding 
section of CAMEO selects all the assembly units of only those structures with biologically 
relevant ligands and evaluates the performances of each participant on the selected targets.  
Ligands 
All the small molecules present in the PDB target structures are categorized in four classes – Ion 
(I), Organic(O), poly-Nucleotide(N), poly-Peptide(P) (as described in 
http://www.cameo3d.org/cameong_help/lb/) – which are derived from the scheme adopted in the 
chemical component dictionary of the PDB. Then, each ligand is classified as ―biologically 
relevant‖, ―irrelevant‖ or ―covalently bound‖ according to the following different criteria: (i) the 
distances between the ligand atoms and the protein, (ii) the annotation of the ligand as a 
commonly observed buffer or crystallization molecule, (iii) the presence/absence of covalent 
bonds between the ligand and the protein. Additionally, a web-based annotation platform allows 
users to manually change these classifications for any ligand bound to a CAMEO target (a 
tutorial page is available at http://www.cameo3d.org/annotation/support). 
Prediction Format 
We developed a new format for the binding site prediction that overcomes the limitations 
observed in the last CASP assessments [5, 6]; however, servers still formatting the predictions in 
the CASP style are allowed to send them to CAMEO, which will automatically perform the 
conversion to the new format. In the CAMEO format, a probability can be assigned either to 
each atom, to each residue or to a mixture of both, for every target chain. In the prediction, each 
entry contains two mandatory and one optional blocks of data, separated by the symbol ―|‖, that 
contain a set of key-value pairs. In the following description of the block structure, the names 
within the symbols ―<‖ and ―>‖ indicate a value, while the data between the symbols ―[‖ and ―]‖ is 
optional. The first section uniquely indicates a residue or an atom; it is mandatory to specify the 
residue name and number, while it is optional to indicate the chain name or the atom name. The 
syntax is: 
―r=<residue name>; n=<residue number>; [c=<chain name>;] [a=<atom name>;] |‖ 
The second section contains the probabilities assigned to each ligand category, which reflect the 
likelihood of a ligand to be in contact with the residue, or with the atom, of the entry; the data 
consists of: 
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―I=<score>; O=<score>; N=<score>; P=<score>; |‖ 
In the third section it is possible to indicate a score for each predicted compound using the three-
letter code of the PDB: 
[<compound i name>=<score>;]. 
Moreover, it is also possible to skip residue or atom entries for which all the probabilities were 
predicted to be zero.  
Baseline homology predictor server 
We implemented three servers to use as baseline methods for the comparison to the participant 
servers. Each one of the three reference server uses a different approach, which is based on 
sequence conservation, geometric binding pocket identification and homology transfer, 
respectively.  
In particular, the server employing the latter approach collects the small molecules present in the 
protein template and places them within the target model. More in detail, the server 
superimposes the template onto the model built by SWISS-MODEL and identifies as members 
of the binding site all those residues that are within 3 Angstroms from a ligand. Finally, the 
server transfers to the model only those ligands which are included in a list of biologically 
relevant molecules (see Table 1 in the Supplementary information chapter) and which fulfil 
different criteria: (i) the ligand must bind at least 3 residues, (ii) the model binding residues must 
be completely conserved, (iii) none of the ligand atoms should be within 1.5 Angstroms from any 
of the protein atoms, and (iv) the RMSD of the binding residues between the template and the 
model must be less than 2 Angstroms. These strict rules allow a high confidence in the 
correctness of the predicted ligands and of their pose within the model. 
The server calculates a score that represents the likelihood of each atom to bind a ligand, using 
a linear function that depends on the distance 𝑑 between the protein‘s atom and the nearest 
ligand atom. The score 𝑠(𝑑) is calculated for each ligand category as: 
𝑠 𝑑 =  
1, 𝑑 < 3
2 −
1
3
𝑑, 3 ≤ 𝑑 ≤ 6
0, 𝑑 > 6
  
and its value is 0.5 with a distance d of 4 Angstroms. 
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Assessment 
A reference probability for each atom is calculated for all the chains in a biological assembly of a 
given target using a sigmoid function, defined as: 
𝑝 𝑑 =
1
1 + 𝑒 1.5𝑑−7.5 
 
where 𝑑 is the distance between a protein atom and a ligand atom. The function parameters 
were optimized to result in a probability of: 
 p(d) = 1 for distances less or equal than 3 Angstroms 
 p(d) = 0 for distances greater or equal than 7 Angstroms 
 p(d) = 0.5 at a distance of 5 Angstroms. 
This probability is calculated for each ligand category. Additionally, if a compound is specified in 
either the organic or ion category, the probability is also computed for that particular compound. 
Each week CAMEO assigns a set of scores to every server using four different methods: the 
Area Under the Curve (AUC), the Pearson‘s correlation coefficient, Spearman‘s rank correlation 
coefficient and Matthew‘s correlation coefficient. The first score can be interpreted as the 
probability that the server assigns a higher score to a binding residue than to a non-binding 
residue. CAMEO defines this score as follows: if an atom has a probability above 0.5, the atom 
is defined as ―binding‖; otherwise, if the probability is below 0.5, it is defined as ―non-binding‖. 
The second score measures the linear correlation between the prediction and the reference 
probabilities, while the third measures the monotonic relationship between the same two sets of 
probabilities. The last score is a correlation coefficient between the predicted and the reference 
classifications of the residues and is used for comparing the server performances with the CASP 
sessions.  
In case multiple chains are present in the reference, in the prediction or in both, the overall score 
assigned to the server is the average over all the best scores calculated for each chain in the 
prediction. Moreover, if the prediction contains all the correct ligands belonging to a certain 
category, the comparison will be based on the probabilities of these single compounds, rather 
than on the value assigned to the whole category. 
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Results and discussions 
The main limitations in CASP ligand binding assessments were the prediction of the binding 
residues without considering the type of the bound ligand and the small number of target 
structures binding biologically relevant compounds. Moreover, only a subset of these proteins 
was considered to be ―difficult targets‖, that is, proteins for which there were no structures or 
ligand annotations associated to close homologs. CAMEO was developed to overcome these 
issues by evaluating the registered servers on the weekly released PDB structures. To date 
(2014-04-11), the number of targets evaluated by CAMEO reached 5260 proteins, containing 
2473 ions, 3877 organics, 351 poly-nucleotides and 119 poly-peptides. An overview of the 
performances obtained over the last 3 months (from 2014-01-10 to 2014-04-11) in the ion and 
organic categories by the registered servers is shown in Figure 4.1.  
 
Figure 4.1 The performances over the last 3 months (from 2014-01-10 to 2014-04-11) of the registered 
servers in CAMEO Ligand Binding within the Ion (left) and Organic (right) categories. Our baseline 
homology predictor server is indicated as ―Naive homology‖ by the light yellow dot. The x axis represents 
the percentage of targets for which a prediction was calculated, while the y axis represents the average 
accuracy calculated on the predicted targets. 
The plots in Figure 4.1 show that our baseline predictor is very good at predicting binding sites 
for ions, but only for about half of the targets received; on the other hand, in the organic category 
our predictor had an average accuracy, but on a low number of targets.  
These results indicate that our baseline method can be used as a first choice for predicting ion 
binding sites, since it showed the best performance in finding the correct residues. However, the 
performances of this server are limited by the small number of templates that bind biologically 
relevant ligands. Therefore, the first improvement to be made would be the analysis of more 
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homologs for a given target, in order to enlarge the available pool of ligands for predicting the 
correct model binding sites. To improve the functional prediction of a model by modelling ligands 
in the predicted binding sites, we developed a new method that takes into account ligands and 
binding sites from the multiple homologs of a target (see chapter 6). 
Supplementary information 
Table 1 Ligands evaluated by SWISS-MODEL. 
Type PDB codes 
Ions CA, CO, CU, CU2, FE, FE2, MG, MN, MO, NA, NI, ZN 
Organic 
molecules 
ADP, AMP, ATP, BTN, COA, BGC, GLC, GDP, GMP, GTP, GSH, FAD, FMN, HEM, 
HEA,HEB, NAD, NAP, NDP, NAI, PLP, SAM, THG, TPP, UDP, CDP, SF4, FES 
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5. SWISS-MODEL: modelling protein tertiary and 
quaternary structure using evolutionary information 
This chapter has been accepted for publication as: 
“SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary 
information”, Marco Biasini1,2, Stefan Bienert1,2, Andrew Waterhouse1,2, Konstantin Arnold1,2, 
Gabriel Studer1,2, Tobias Schmidt1,2, Florian Kiefer1,2, Tiziano Gallo Cassarino1,2, Martino 
Bertoni1,2, Lorenza Bordoli1,2 and Torsten Schwede1,2,*. Nucleic Acids Research. 
1 Biozentrum, University of Basel, Basel, 4056, Switzerland 
2 SIB Swiss Institute of Bioinformatics, Basel, 4056, Switzerland 
Contribution: I developed and implemented the part of the SWISS-MODEL pipeline that models 
ligands into the protein model structures. 
Abstract 
Protein structure homology modelling has become a routine technique to generate three-
dimensional models for proteins when experimental structures are not available. Fully automated 
servers such as SWISS-MODEL with user-friendly web interfaces generate reliable models 
without the need for complex software packages or downloading large databases. Here, we 
describe the latest version of the SWISS-MODEL expert system for protein structure modelling. 
The SWISS-MODEL template library provides annotation of quaternary structure and essential 
ligands and co-factors to allow for building of complete structural models, including their 
oligomeric structure. The improved SWISSMODEL pipeline makes extensive use of model 
quality estimation for selection of the most suitable templates and provides estimates of the 
expected accuracy of the resulting models. The accuracy of the models generated by SWISS-
MODEL is continuously evaluated by the CAMEO system. The new web site allows users to 
interactively search for templates, cluster them by sequence similarity, structurally compare 
alternative templates, and select the ones to be used for model building. In cases where multiple 
alternative template structures are available for a protein of interest, a user-guided template 
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selection step allows building models in different functional states. SWISS-MODEL is available 
at http://swissmodel.expasy.org/. 
Intoduction 
SWISS-MODEL (http://swissmodel.expasy.org/) is an automated system for modelling the three-
dimensional structure of a protein from its amino acid sequence using homology modelling 
techniques. SWISS-MODEL has been established 20 years ago as the first fully automated 
server for protein structure homology modelling, and has been continuously developed and 
improved since then [1, 2] [3] [4]. The server features a user-friendly web interface, which allows 
also non-specialists to generate three-dimensional models for their protein of interests from a 
simple web-browser without the need to install and learn complex molecular modelling software, 
or to download large databases [5]. Today, SWISS-MODEL is one of the most widely used 
structure modelling web servers world-wide, with more than 0.9 million requests for protein 
models annually (i.e. approximately one model per minute). Recently, its functionality has been 
greatly extended: SWISS-MODEL now models oligomeric structures of target proteins, and 
includes evolutionary conserved ligands such as essential cofactors or metal ions in the model. 
A newly developed interactive web interface allows users to conveniently search for suitable 
templates using sensitive HMM searches against the SWISS-MODEL Template Library (SMTL), 
analyse alternative templates and alignments, perform structural superposition and comparison, 
explore ligands and cofactors in templates, and compare the resulting models using mean force 
potential based model quality estimation tools. Model quality estimation is an essential 
component of protein structure predictions, as the accuracy of a model determines its usefulness 
for practical applications. SWISS-MODEL provides model quality estimates (visually in the web 
page and numerically for download) based on a QMEAN potential [6] [7] specifically re-
parameterized for models build by SWISS-MODEL. The accuracy of the SWISS-MODEL server 
is independently evaluated in comparison with other state-of-the-art methods by the CAMEO 
project (http://cameo3d.org/; Continuous Automated Model EvaluatiOn) [8] based on target 
sequences weekly pre-released by the PDB [9]. 
Materials and Methods 
Overview 
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Homology modelling (or comparative modelling) relies on evolutionarily related structures 
(templates) to generate a structural model of a protein of interest (target). The process typically 
comprises the following steps: (I) Template identification; (II) Template selection; (III) Model 
building; and (IV) Model quality estimation [10] [11]. In brief, a library of experimentally 
determined protein structures is searched with sensitive sequence search tools to identify 
proteins which are evolutionary related to the target protein. If one or more templates are 
identified, the information of the alignment of the target and the template sequences together 
with the 3-dimensional coordinates of the template(s), are used to build a structural model for the 
protein of interest. Finally the quality of the computed model is estimated to indicate the 
expected quality and suggest possible application of the obtained model.  
The SWISS-MODEL Template Library (SMTL) 
Comparative modelling methods make use of information from experimentally determined 
protein structures to generate models for a target protein. A well-curated and annotated template 
library which supports efficient queries is therefore a crucial component of a modelling server. 
The SMTL aggregates information of experimental structures from the PDB (9) and augments it 
with derived information. When a new structure is released by the PDB, the coordinates and 
accompanying information are processed and imported into the template library. SMTL entries 
are organized by likely quaternary structure assemblies, termed ―bio units‖, which are created 
according to the author- and software annotated oligomeric states listed in the PDB deposition. 
Template amino acid sequences are indexed in a searchable databases for BLAST [12], and 
added to a HMM library that can be searched by HHblits [13]. Sequence Profiles, predicted 
secondary structure (SSpro [14], PSIPRED [15]), predicted solvent accessibility (ACCpro [14]), 
per-residue solvent accessibility, (NACCESS (S. Hubbard and J. Thornton)), secondary 
structure (DSSP [16]) are calculated and stored alongside the structure. In addition, protein 
purification tags, such as HIS or TAP tags are detected in the sequences and marked as such. 
The implementation of computational routines in SMTL is based on OpenStructure [17]. 
Annotation of Ligands in SMTL 
In most crystal structures low molecular weight ligands are observed, but only some of those are 
functionally or structurally relevant for the protein. Instead of their natural ligands, some 
structures contain synthetic analogues or inhibitors which occupy competitively the same binding 
site. Often, buffer or precipitant molecules are encountered, which are added by 
experimentalists to facilitate crystallization. SMTL implements a two-stage process to annotate 
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biologically relevant ligands and synthetic analogues. The first stage uses a list of rules to 
automatically categorize the ligands based on their chemical identity. For example, all potassium 
ions are classified as solvent at this stage. In a second stage, the SMTL web interface provides 
a way to change the ligand classification manually. For example, in case of a potassium channel 
structure some of the before-mentioned potassium ions may be re-annotated as biologically 
relevant. While re-annotations can be suggested by any SWISSMODEL user, before taking 
effect in SMTL, the annotations are reviewed by a curator to guarantee high quality of 
annotations. 
Template Search and Selection 
The SWISS-MODEL Template Library is searched in parallel both with BLAST and HHblits to 
identify templates and to obtain target-template alignments. The combined usage of these two 
methods guarantees good alignments at high and low sequence identity levels [18]. In order to 
select the most suitable templates, the procedure implemented in SWISS-MODEL uses 
properties of the target-template alignment (sequence identity, sequence similarity, HHblits 
score, agreement between predicted secondary structure of target and template, agreement 
between predicted solvent accessibility between target and template; all normalized by 
alignment length) to predict the expected quality of the resulting model (Biasini, M., et al, 
manuscript in preparation). In brief, each of the alignment properties is modelled as probability 
density function (PDF) of the estimate for a resulting model having a certain structural similarity 
to the target. The use of PDFs has the advantage of at once including the expectation value as 
well as the accuracy of the estimate for each property. It also takes into account, that some 
properties are better (more accurate) at predicting the quality at high levels of sequence identity, 
whereas others are more accurate in the twilight zone of sequence alignments. For each 
property the most likely structural similarity of the template to the target is the value at which the 
PDF is maximal. Properties are combined based on their relevance, which has been determined 
from large sets of target/template alignments with known target structures. When combining the 
estimates of each property, the most likely structural similarity is the value at which the joint 
distribution is maximized, termed the global quality estimation score (GMQE). 
Model Building and Scoring 
After templates are selected for model building, either by using the automated or manual 
selection mode, the target/template alignment is used as input for generating an all-atom model 
for the target sequence using ProMod-II [19]. In case loop modelling with ProMod-II does not 
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give satisfactory results, an alternative model is built with MODELLER [10]. By default, models 
are built using the homo-oligomeric structure of the template as annotated in SMTL, provided the 
oligomeric structure is predicted as conserved (see Oligomeric Structure Prediction below). An 
indispensable part of every modelling procedure is the estimation of a protein model‘s accuracy, 
directly providing the user with information regarding the range of its possible applications [11, 
20, 21]. Here, model quality is assessed with the local composite scoring function QMEAN, 
which uses several statistical descriptors expressed as potentials of mean force: geometrical 
features of the model (pairwise atomic distances, torsion angles, solvent accessibility) are 
compared to statistical distributions obtained from experimental structures and scored. Each 
residue is assigned a reliability score between 0 and 1, describing the expected similarity to the 
native structure. Higher numbers indicate higher reliability of the residues. The weights of 
QMEAN have been specifically retrained for SWISS-MODEL, leading to more accurate local 
quality predictions for single models (Studer, G., et al., manuscript in preparation). In addition, 
global QMEAN scores are calculated as indicators for the overall model quality. Global QMEAN 
estimates are provided as a Z-score which relates the obtained values to scores calculated from 
a set of high-resolution X-ray structures [7]. Additionally, a combined quality estimate is 
provided, which combines the QMEAN estimate with the GMQE obtained from the target-
template alignment as described before. The resulting GMQE is again expressed as a number 
between zero and one, where higher numbers indicate higher reliability. 
Oligomeric Structure Prediction 
The majority of proteins in a living cell exist as part of complexes and quaternary structure 
assemblies, monomeric proteins being the exception rather than the rule [22]. Frequently, ligand 
binding sites and enzyme active sites are located at protein chain interfaces, and modelling of 
the oligomeric structure of a protein is therefore essential to build models which are useful in 
biomedical applications [23]. Here, the homo-oligomeric structure of a target protein is modelled 
based on the hypothesis that the quaternary structure is conserved in one of the templates. To 
test this hypothesis, conservation of the oligomeric structure is predicted by analysing properties 
of interfaces between polypeptide chains such as sequence identity, sequence similarity, 
interface hydrophobicity, and consensus occurrence of the same interface in the set of identified 
templates. A random forest is generated using these features as input parameters to predict the 
probability of conservation for each interface. When the size-weighted average of interface 
conservation is higher than a defined threshold, the oligomeric structure of the target is predicted 
to be the same as in the template. 
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Modelling of Ligands 
For predicting essential ligands and cofactors for a given target protein, we apply a conservative 
homology transfer approach to small molecules which are observed in the templates identified in 
the SMTL. Ligands in SMTL are annotated either as: a) relevant, non-covalently bound ligand, b) 
covalent modifications, or c) non-functional binders (e.g. buffer or solvent). A non-covalently 
bound ligand is considered for the model if the coordinating residues are conserved in the target-
template alignment. The relative coordinates of the ligand are transferred from the template, if 
the resulting atomic interactions in the model are within the expected range for van der Waals 
interactions and water mediated contacts. 
Performance of the Method (CAMEO) 
The performance and reliability of the SWISS-MODEL server is continuously evaluated by the 
CAMEO project (Continuous Automated Model EvaluatiOn) [8]. Modelling servers are blindly 
assessed based on sequences pre-released by the PDB for proteins which structure will be 
published in the next release. Servers have four days to predict the 3-dimensional structure of 
the target proteins before models are evaluated against the protein structure coordinates 
released by the PDB using superposition-independent scoring methods such as CAD score [24] 
and lDDT [25]. The current CAMEO evaluation for this version of SWISS-MODEL consist of 
6424 predictions for 599 target proteins collected over 52 weeks (i.e. from 2013-03-01 to 2014-
02-28; data available at http://cameo3d.org). SWISS-MODEL accuracy is compared to other 
state-of-the-art protein structure prediction servers [26-32] and to previous version of the server 
[5]. 
Webserver Implementation 
The web frontend to SWISS-MODEL follows the typical design of modern websites where 
business logic is implemented in JavaScript and executed directly in the browser. For improved 
user-interaction, data is fetched asynchronously from the server, without the need to reload the 
complete page. The front-end uses jQuery (jquery.com) to guarantee cross-browser 
compatibility. For 3D structure visualization, the user can chose between a modified version of 
OpenAstexViewer (openastexviewer.net) Java plugin, and the WebGL-based PV 
(https://biasmv.github.io/pv). The frontend communicates with a Django 
(www.djangoproject.com) backend that handles all incoming requests. Computationally 
demanding calculations, e.g. template search and modelling, are submitted via a queuing 
system to a dedicated compute cluster. 
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SWISS-MODEL web interface 
Input. Model building with SWISS-MODEL can be initiated from different starting information: In 
the simplest case, a protein amino acid sequence can be specified directly (raw one letter 
sequence or FASTA format) or by referring to its UniProt accession code, in which case SWISS-
MODEL will automatically retrieve the corresponding entry from UniProt [33]. Alternatively, a 
target-template sequence alignment can be specified in the form of a multiple sequence 
alignment containing the target, the template, and eventually other homologous sequences, or in 
the form of a DeepView project file [3, 19]. At this point, the user can initiate the template 
selection step, which allows to manually select specific templates, or directly invoke the fully 
automated modelling pipeline.  
Output template search results and manual template selection. Thanks to tremendous technical 
advances in experimental structure determination, for an increasing number of protein families 
there is not only one template, but multiple alternative template structures available. For some 
well-studied protein families, finding hundreds of possible templates for a target protein is not 
unusual. Often, these represent different functional states or structures in complex with different 
ligands. Depending on the intended application of a model, selecting a different template than 
the top-ranked one might be necessary, e.g. to build a model of a protein in complex with a 
ligand – rather than its apo form – for applications in drug design when induced fit movements 
are expected [34]. We have therefore developed a manual template selection mode to make 
template selection available to a larger user base. All the steps of manual template selection can 
be performed directly in the web-interface without the need to leave the browser environment 
(Figure 1). 
Suitable templates identified for the target sequence are listed in a tabular form, sorted by their 
predicted global quality estimation score (GMQE). Each template lists biologically relevant 
ligands, the predicted oligomeric structure conservation and the target-template alignment. The 
tabular view allows quickly gaining an overview on the identified templates. The user can directly 
select one or more templates and initiate model building. Apart from comparing template 
properties in tabular form, two graphical comparison views help to better understand the 
landscape of available templates. An interactive 3D view of superposed templates shows the 
aligned part of selected template structures (Figure 1C), at the user's choice using a WebGL-
based (PV), or Java-based (OpenAstex) viewer. The second view shows the evolutionary 
distance between templates on 2D plot (Figure 1A).  
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Figure 1. Templates Selection and Visualization. (A) An interactive chart shows the relationship of 
detected templates in sequence-similarity space. The target protein is represented as filled red circle. 
Each template is displayed as a blue circle, where the thick blue arc indicates target coverage (the N-
terminus of the target protein starts at the top of the circle, and ends in clockwise direction with the C-
terminus to close the circle). The distance between different templates is proportional to the pairwise 
sequence similarity, i.e. evolutionarily closely related templates will clustered together. (B) Clicking on a 
circle will display template-specific information. A group of similar templates can be also visualized and 
selected by hovering over a cluster of templates. (C) The superposed structures of the selected templates 
will be instantaneously displayed in 3D to visually inspect structural differences.  
Groups of high-sequence identity templates cluster together, whereas more distant proteins are 
separated. The interactive graph allows marking groups of templates for structural superposition 
by selecting them with the cursor. The sequence similarity cluster view in combination with 
template superposition allows identifying functionally relevant states of the templates (―open / 
closed‖). It also supports defining structurally conserved cores in the identified template 
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structures, and such regions where template which are not closely related share common 
structural features, are most likely well modelled in the target, while segments of structural 
variation in templates typically correlate with errors in the model [30, 35].  
Output modelling. For each model generated based on the selected templates (either by the fully 
automated pipeline or interactively by the user), SWISS-MODEL provides the model coordinates 
along with relevant information to assess the modelling process and expected accuracy of the 
model (Figure 2): the target-template alignment, a step-by-step modelling log, information about 
the oligomeric state, ligands and cofactors in the model, as well as QMEAN model quality 
estimation. Models can be displayed interactively, initially coloured by model quality estimates 
assigned by QMEAN to highlight regions of the model which are well or poorly modelled. If 
several alternative models have been built for a target sequence, these can be interactively 
superposed and visualized. Model coordinates and information displayed on the website can be 
downloaded for later reference. 
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Figure 2. Modelling Results. (A) For each model, coordinates, target-template alignment, modelling log, 
and quality estimation information are provided. Information about the oligomeric structure, ligands and 
cofactors is also provided. (B) The colouring of the target-template sequence alignment can be changed to 
another scheme by clicking on the option button (adjustable spanner icon). Changes are simultaneously 
reflected in the structural representation of the model. (C) Models displayed in the interactive viewer are 
initially coloured by model quality estimates assigned by QMEAN. This allows instantly discriminating 
regions of the model which are well or poorly modelled. Local estimates of the model quality based on the 
QMEAN scoring function are shown as per-reside plot (A) and global score (GMQE) in relation to a set of 
high-resolution PDB structures (Z-score) (D). 
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Discussion and conclusions 
Protein structure homology modelling has become a routine method to provide structural models 
on life science research in cases where no experimental structures are available. However, in 
order to support the understanding a protein‘s function in its biological context, realistic structural 
models should not only correctly represent the overall fold of a single protein chain, but also its 
quaternary structure, as well as the atomic details of interactions with essential cofactors and 
ligands. Modelling and assessment procedures must also be able to account for structural 
flexibility since proteins are not static entities, but may exist in structurally distinct functional 
states. With the new version of SWISS-MODEL presented here, we aimed to address these 
aspects by introducing a new augmented SWISS-MODEL Template Library, which includes 
information on quaternary structures and the role of ligands bound to the template. At the same 
time, we have significantly improved the accuracy of the fully automated SWISS-MODEL 
pipeline, aiming to reliably provide accurate models which are useful for applications in 
biomedical research. The expected accuracy of each specific model is communicated to the 
user in the form of QMEAN score, and the overall accuracy of SWISS-MODEL is continuously 
monitored in CAMEO. The implementation of the new web interface allows users to interactively 
compare alternative templates and select those which are more suitable for the intended 
application of the model (e.g. based on the presence / absence of specific ligands or structurally 
different functional states). The interactivity of the new web site required the usage of innovative 
programming techniques for the web front end, as well as speed optimization and hardware 
upgrades of the backend in order to provide a satisfying user experience. 
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6. Modelling cofactors in homology models 
This chapter describes the work in preparation for the manuscript: 
―Modelling cofactors in homology models by evolutionary inference‖, Tiziano Gallo Cassarino1,2 
and Torsten Schwede1,2 
1. Biozentrum, University of Basel, Switzerland 
2. SIB Swiss Institute of Bioinformatics, Basel, Switzerland 
Abstract 
Recent developments in the field of ligand binding site prediction, assessed during the last 
CASP editions, indicate that the currently best performing methods make use of the close 
homologs of a target protein to infer its binding residues. Our aim is to extend this approach to 
the modelling of ligands, in particular ions and organic cofactors, in homology modelled protein 
structures. By comparing the target with a set of its homologous templates, we analyse several 
properties of their binding sites and find the best similarity descriptor to identify the most likely 
ligands that should be placed in the target model. To verify the quality of this approach, we 
assessed the performances of our method against the two leading prediction servers, COACH 
and RaptorX-Binding, from the CAMEO Ligand Binding category. Using a blind-test approach on 
a dataset consisting of several hundreds of protein structures, we show that our method 
performs clearly better than the other two servers, with the best precision-recall for ions and the 
highest sensitivity for organic cofactors. 
Introduction 
One of the biggest challenges in Biology is to reduce the gap between the ever-growing number 
of protein sequences deposited in public databases and, on the other hand, the relatively small 
fraction of these for which a biological function is known. A fundamental help in understanding 
protein functions is provided both by their 3D structure and by the interactions they are involved 
in with other molecules. To this purpose, it is necessary to identify which protein residues 
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participate in these interactions and, most interestingly, which molecules can serve as ligands 
within a protein binding pocket. Moreover, a deeper knowledge of protein binding preferences 
has proved to be essential to identify novel therapeutic targets [1], but also to discover natural 
ligands by structure-based drug design [2]. Current methods providing functional annotation at 
the residue level can be classified according to the main approach they adopt, which can be 
based either on the protein sequence [3-5] or on its structure [6-11]. 
Methods belonging to the first group usually measure each residue's conservation within 
homologous proteins and define as "binding residues" the most conserved amino acids in the 
sequence. However, although a clear advantage of this approach is that it can be used even 
when the protein structure is unknown, the main drawback is that some residues considered to 
be functional might have actually been evolutionarily conserved for other reasons (for instance, 
they might be involved in protein-protein interfaces or in maintaining protein stability). 
On the other hand, the methods belonging to the second group, which adopt protein structure to 
identify binding residues, can be further distinguished in those that recognize protein surface 
cavities (for an example, see [8]) and those that infer the target binding residues from its 
homologous proteins (for an example, see [9]). Although pocket detection algorithms can be 
more successful in case the target has only distant homologs, these methods are outperformed 
in the opposite scenario - that is, when close homologs are available - as shown in the last 
edition of the community-wide Critical Assessment of protein Structure Prediction (CASP) 
competition under the "FN category" [12] and, more recently, in the Ligand Binding category of 
the Continuous Automated Model Evaluation (CAMEO) server (http://cameo3d.org/lb/). 
Overall, the main objective of the above mentioned approaches is focussed on the identification 
of the specific residues which might be in contact with a ligand. However, so far only few 
attempts have been done to predict, in addition, the precise ligand conformation in the model (for 
an example, see [13]) and, thus, to provide a complete functional annotation for the protein of 
interest. 
In this study, we contribute to improve the knowledge about a target protein by inferring its 
natural, i.e. biologically relevant, small molecule ligands and by placing these in the most likely 
conformation within the modelled structure. Our method analyses the similarities between the 
target structure and the ligand binding sites of its homologous proteins; a range of features are 
tested and compared, the best of which is used in the final implementation of the ligand 
modelling method. Moreover, we also extract and integrate the annotations from UniProt [14] 
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and from the SWISS-MODEL Template Library (SMTL) (see chapter 5), regarding all ligands 
interacting with the target's homologous proteins. Finally, the model binding site(s) are identified 
and filled (when possible) with the small molecules they are most compatible with. In a blind test 
using 364 targets provided by CAMEO, we compare the performances of our method to two 
state-of-the-art ligand binding predictors and we demonstrate that our method performs 
significantly better than the other two. 
Methods 
Datasets 
To create a training dataset containing as many correctly bound ligands as possible, we built a 
non-redundant training set of high quality PDB protein chains that are experimentally annotated 
as binding ions (Cobalt, Calcium, Copper, Iron, Magnesium, Manganese, Nickel, Zinc) or organic 
cofactors, like S-adenosyl-L-methionine, Biotin or Flavin adenine dinucleotide (the full list can be 
found at CoFactor database: http://www.ebi.ac.uk/thornton-srv/databases/CoFactor/). 
We used the EMBOSS suite 6.2.0 [15] to fetch all those UniProt-SwissProt (UniProt release 
2013_05) entries which are annotated to bind one of the above mentioned molecules in the 
Sequence annotation (Features) field. Next, we retrieved the associated PDB code by using the 
SIFTS service [16]. From this pool of proteins, we only kept the high quality chains (X-Ray 
resolution <= 2Angstrom and R-Free <=0.25) bound to a ligand which was not located in an 
interface and which was in contact with the residues indicated by SwissProt. Following previous 
indications in the literature, for example in [17], this filtering step ensured that: (i) the ion-protein 
distances were in agreement with the Cambridge Structural Database (CSD) [18] statistics and 
(ii) the ion in the PDB structure was reliably identified. 
For each small molecule, we obtained a non-redundant set of protein domains by clustering all 
protein chains bound to the selected ligand on the basis of the PFAM classification [19] (as of 
2013-06-25) and by keeping only one member of each cluster as representative of the whole 
protein family domain. The resulting set was composed by 434 monomers bound to 495 small 
molecules, of which 352 are ions and 143 are organic cofactors. Afterwards, we built a model of 
each protein using the SWISS-MODEL server and we filtered out the templates belonging to our 
training set.  
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A large scale blind-test was used to assess the performances of our approach in comparison to 
other two state-of-the-art methods. The testing set used to this purpose was built by collecting 
the target proteins sent weekly by CAMEO to our and to the other two participants with the best 
performances, RaptorX-Binding (http://raptorx.uchicago.edu/BindingSite/) and COACH [11], in 
the Ligand Binding category of the Continuous Automated Model EvaluatiOn server (CAMEO). 
The models produced by these two participants were retrieved through the data sent by each 
participant to CAMEO Ligand Binding. For COACH, we considered the representative ligand of 
the best scoring cluster, while for RaptorX-Binding we used the compound indicated for each 
pocket. 
CAMEO tries to validate the biologically relevance of ligands with a crowd-sourcing approach 
through an annotation platform; therefore, CAMEO targets could contain both biologically and 
non-biologically relevant compounds. To exclude irrelevant small molecules that have not been 
manually curated, we kept in the structures only those ligands included in a list of known natural 
occurring, or "cognate", compounds (as in Table 2 within the Supplementary information 
chapter), that we retrieved from the FireDB database [20]. Moreover, we excluded those 
―cognate‖ ligands that could be irrelevant for a specific target structure by removing all the 
molecules not bound to at least three protein residues, or present more than 15 times. All the 
targets that did not bind at least one relevant molecule were removed from the testing set. 
A total of 614 target structures, and the corresponding server models, were collected between 
2014-01-10 and 2014-04-04; among these, there were 364 proteins bound to 1004 biologically 
relevant ligands, of which 555 were ions, 436 organic, 7 nucleotides and 6 polypeptides, 
according to the CAMEO classification of hetero-compounds. The complete list of ligands and of 
their frequencies can be found in Table 1 within the Supplementary information chapter. The 614 
targets correspond to about 300 different protein domains, which are homogeneously distributed 
(Fig. 6.1). 
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Figure 6.1 Distribution of the small molecules within the CAMEO targets used in the testing set. In cyan 
are indicated ions, in magenta organic ligands and in yellow the category of polynucleotides. FAD 
indicates Flavin-adenine dinucleotide and GLY is Glycine. For clarity, only the ligands representing at least 
1% of the dataset are shown. 
Training 
During the training step, we predicted ligands by using seven different scores based on various 
properties of template and target proteins. In addition, we implemented an annotation score that 
takes into account UniProt annotations, in order to assign a higher weight to those ligands for 
which there is an experimental evidence of binding. This score, described in the previous section 
as the fraction 10 𝑢 𝑏 , was summed to the following seven scores: 
(i) the fraction score, named freq, which is the ratio between the number of ligands of a 
given type and the total number of ligands in the cluster; 
(ii) the sequence conservation score, named cons, of a ligand binding site; cons is the 
normalized average entropy of the ligand binding residues and is calculated using the 
Jensen-Shannon Divergence (JSD) implemented in [13]; 
(iii) the functional specificity score of a binding site, named sdp_bres, defined as the 
average score obtained by implementing a modified version of the method described 
in [14]. In that study, the aim was to identify subgroups in protein families through the 
Specificity Determinant Positions (SDP) and each residue's score ranged from 0 for 
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conserved residues to minus infinite for a very specific position. In our case, both 
conserved and specific residues are considered relevant, such that the score 
assigned to a ligand is the average of the standardized absolute SDP values of the 
binding residues; 
(iv) the local structural similarity score, named rmsd, derived from the RMSD between 
the template ligand site and the aligned model site, using a logistic function: 
𝑝 = 1 +
−1
1 + 𝑒−3(𝑅𝑀𝑆𝐷−2)
 
where a RMSD of 2 Angstroms results in a probability of 0.5. The RMSD is calculated 
by TMAlign [15] in the superimposition between the template binding site – defined 
as all the residues within 10 Angstroms from the ligand – and the corresponding 
model residues; 
(v) the structural sequence identity, named str_seqid, considers the fraction of annotated 
binding residues and the sequence identity between a template binding sites and a 
model pocket, as described in the following Algorithm section; 
(vi) the sequence identity, named seqid, calculated performing a local alignment between 
the subset of the template residues which are in contact with the ligand and the 
corresponding model residues found in the target-template alignment from SWISS-
MODEL; 
(vii) the aggregated score, named rank, defined as the sum of the annotation score, the 
RMSD-based probability, the structural sequence identity and, only for ions, the 
fraction score. 
Algorithm 
Overall, our algorithm collects and assigns a score to all the small molecules present in the 
homologous structures (the "templates") found by SWISS-MODEL for a target sequence; then, 
the ligands with the best scores are transferred to the model structure and a report for the 
SWISS-MODEL website is provided. 
More in detail, the initial step consists in the identification of candidate ligands, which should be: 
(i) bound to the template structure and (ii) considered as "biologically relevant". To satisfy the 
first criterion, a molecule must have at least 3 protein residues within 4 Angstroms (3.2 in case of 
ions and Fe-S clusters). From now on, the ligand binding site will be composed by the residues 
within this distance. Regarding the second criterion, we give priority to molecules that are listed 
in the SWISS-MODEL Template Library (SMTL) Ligand Annotation system (see chapter 5), 
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which is a semi-manually curated database of ligand ontologies. In case the molecule is not 
annotated in SMTL or it is annotated as "Non-covalent", the algorithm checks whether it is 
contained in: (i) a list of known natural compounds or (ii) a list of biological molecules that can be 
used as buffer or solvent (for example sulfate ions) and, at the same time, among the UniProt 
ligands. These two manually curated lists are adapted from the FireDB [20] "Cognate" (see 
Table 2 in the Supplementary information) and "Ambiguous" ligands (see Table 3 in the 
Supplementary information), respectively. 
Ligands defined as "biologically relevant" are subsequently clustered and scored. Any two 
ligands belonging to different templates are considered to be in the same group when at least 
one third of the ligand binding residues for one of them (or simply two residues, for ions), are 
aligned in the merged pair-wise alignment produced by SWISS-MODEL for the target and its 
homologous protein sequences.  
After the clustering step, each ligand receives a score corresponding to the sum of two terms: 
the first is the weighted fraction of the template binding residues annotated in UniProt; the 
second is the sequence identity, calculated from the structural alignment between the ligand 
binding residues and the corresponding residues in the model. These residues are found by a 
sequence independent superimposition – calculated by TMAlign [21] – of the full structure of the 
template containing the ligand on the model structure. A second superimposition of only the 
binding residues is performed to produce a refined local structural alignment, allowing a refined 
placement of the ligand into the model. The score 𝑠 assigned to a ligand is finally calculated as: 
𝑠 = 10
𝑢
𝑏
+
𝑚
𝑏
 , 
where 𝑢 is the number of binding residues annotated in UniProt, 𝑚 is the number of matching 
residues (i.e. with the same one letter code) between the template and the model binding site, 
while 𝑏 is the number of ligand binding residues. In order to rank the ligands primarily on the 
UniProt annotation, the fraction of annotated binding residues (that is, the term 𝑢 𝑏  ) is 
multiplied by 10.  
After a close inspection of the training set, we decided to set the binding site sequence identity 
(𝑚 𝑏 ) cutoff to 0.25; in this way, we avoid to transfer ligands into a model binding site which is 
unrelated to the template ligand binding site. For each cluster where at least one ligand has a 
score s greater than zero, the best scoring ligand that fits the model pocket is transferred into it. 
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Assessment 
To assess the accuracy of our method, we need to identify which modelled ions and cofactors 
correspond to the molecules bound to the target structure. The first step is to superimpose the 
model to the target; then, for each of ligand in the target, we look for small molecules in the 
model within 3 Angstroms of the ligand centre. The similarity between the found molecules and 
the target ligand is compared using the Tanimoto score (calculated using the SMSD software 
[22]) in case of organic ligands; instead, in case of ions, the similarity is measured only using the 
atom‘s element, without considering the oxidation state. A model ligand is evaluated as wrong if 
it belongs to a category (ions or organics) different from the target ligand, while it is considered 
correct either if it has a chemical similarity greater than 0.77, or, for ions, if it has the same 
element as the target ligand. The ability of our predictor to place the correct ligands into the 
model is assessed using the recall versus the precision plot. The precision, also called Positive 
Predicted Value (PPV), and the recall, i.e. the sensitivity or True Positive Rate (TPR), are 
calculated as: 
𝑝𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛 =
𝑇𝑃
𝑇𝑃 + 𝐹𝑃
 , 𝑟𝑒𝑐𝑎𝑙𝑙 =
𝑇𝑃
𝑇𝑃 + 𝐹𝑁
 
where TP is the number of correct ligands that are placed in the right binding site of the model, 
FP is the number of ligands in the models that are not present in the target structures or that are 
in the wrong binding site and FN is the number of target ligands that were not placed in the 
models. A high precision means that most of the ligands placed in the models are correct, while 
a high recall indicates that most of the target ligands are included in the models. These 
measures are employed first in the training and later in the testing phase to compare our method 
with the performances of COACH and RaptorX-Binding.  
Whenever a ligand is correctly predicted, we measure how much the ligand conformation is 
similar to the corresponding molecule present in the target structure by superimposing their 
binding sites. In case of organic ligands we use the RMSD between the ligand atoms 
coordinates in the target structure and the corresponding ligand within the model. In case of 
ions, we measure the distance between the atom in the target structure and the corresponding 
ion atom in the model. As we are interested only in the ligand conformations and positions 
respect to the target, we do not exclude correct ligands that overlap badly modelled binding 
sites. 
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Results 
In order to check which of the seven scores used by our algorithm was best performing on ions 
and organic ligands, we measured their precision-recall values on the training set, as shown in 
the Figures 6.2 and 6.3. Overall, for each scoring method, the recall was higher for the ion 
category than for the organic ligands, while the precision had the opposite trend, being greater 
for organics than for the ions. Two clusters can be identified in the precision-recall plots: the first 
group, on the left side of the plot, composed by scores (cons and sdp_b-res) based on the 
evaluation of the merged pairwise alignment between the target and all the templates; the 
second group, on the right side of the plot, including the remaining scores, which take into 
account the similarity between each single pair of target-template binding site. A special case is 
constituted by the fraction score freq, which considers all the ligands in all the templates and, 
thus, is more similar to the first than to the second group. The structural sequence identity score, 
str_seqid, achieved the best precision both for the prediction of ions (0.67) and of organic 
ligands (0.83), while the recall was similar to that of the other features (0.88), meaning that this 
type of score allows the identification of more correct than incorrect ligands with respect to the 
other measures. 
 
Figure 6.2 Precision-recall plot of the performances for ion predictions achieved by using different scores. 
Str_seqid is the structural sequence identity score, seqid is the sequence identity measure, rmsd is the 
local structural similarity, rank is the rank score, freq is the fraction score, cons is the conservation score 
and sdp_b-res is the specificity score. 
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Figure 6.3 Precision-recall plot of the performances for organic ligand predictions achieved by using 
different scores. Str_seqid is the structural sequence identity score, seqid is the sequence identity 
measure, rmsd is the local structural similarity, rank is the rank score, freq is the fraction score, cons is the 
conservation score and sdp_b-res is the specificity score. 
From the point of view of the ligand conformation accuracy, shown in Figures 6.4 and 6.5, a first 
observation is that, in each plot, the distribution of the RMSDs was very similar across all the 
different types of scores. For ions prediction, the median was around 0.2 Angstroms and the 
upper quartile was below 0.5 Angstroms, while for the organics prediction the median was less 
than 0.7 Angstroms and the upper quartile around 1 Angstrom. Only in the organic category, we 
noticed that the cons and sdp_bres scores showed a broader distribution than the other scoring 
methods.  
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Figure 6.4 Distributions of the distances, for each ion, between its position within the model and the 
target, achieved by using different scores. Red lines indicate medians; blue boxes show the upper (75%) 
and lower (25%) quartile; whiskers are 1.5 times the upper and lower quartile; blue crosses correspond to 
the outliers. Str_seqid is the structural sequence identity score, seqid is the sequence identity measure, 
rmsd is the local structural similarity, rank is the rank score, freq is the fraction score, cons is the 
conservation score and sdp_bres is the specificity score. 
Since the score str_seqid achieved the best precision, while maintaining recall and RMSD 
distributions with very similar values to the other approaches, we decided to employ it for the 
testing phase. To assess the performances of our method against COACH and RaptorX-Binding 
servers, we compared the precision-recall values and the RMSD distributions between the target 
and the subset of ligands which were correctly predicted. Table 6.1 shows the values of True 
Positives (TP), False Positives (FP) and False Negatives (FN) together with precision and recall, 
grouped by the ligand category and the server. 
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Figure 6.5 Distributions of the RMSDs, for each organic cofactor, between its position within the model 
and the target, achieved by using different scores. Red lines indicate medians; blue boxes show the upper 
(75%) and lower (25%) quartile; whiskers are 1.5 times the upper and lower quartile; blue crosses 
correspond to the outliers. Str_seqid is the structural sequence identity score, seqid is the sequence 
identity measure, rmsd is the local structural similarity, rank is the rank score, freq is the fraction score, 
cons is the conservation score and sdp_bres is the specificity score. 
 
Table 6.1 Counts of FN, FP, TP with precision and recall values in the ions and organics category 
obtained by our method, using the str_seqid score, COACH and RaptorX-Binding. 
Ions str_seqid COACH RaptorX 
 
Organics str_seqid COACH RaptorX 
FN 191 400 302 
 
FN 214 287 230 
FP 172 73 160 
 
FP 208 89 179 
TP 237 29 83 
 
TP 167 88 90 
precision 0.580 0.284 0.342 
 
precision 0.445 0.497 0.335 
recall 0.554 0.068 0.216 
 
recall 0.438 0.235 0.281 
 
In Figure 6.6 and Figure 6.7 we show the precision-recall values, while Figure 6.8 and 6.9 
display the RMSD distributions of COACH, RaptorX-Binding and our method. In the prediction of 
ions, our method performed clearly better than the other two servers, with a precision of 0.58 
and a recall of 0.55. In the organics category, our method showed a slightly lower precision 
(0.45) than COACH (0.50), although it reached the best recall (0.44). 
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Figure 6.6. Precision-Recall achieved by our method (using the score str_seqid), COACH and RaptorX-
Binding in the ion predictions. 
 
 
Figure 6.7. Precision-Recall achieved by our method (using the score str_seqid), COACH and RaptorX-
Binding in the organic ligand predictions. 
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Figure 6.8. Distance distributions of the correctly predicted ligand conformations produced by our method 
(str_seqid), COACH and RaptorX-Binding. 
 
 
Figure 6.9. RMSD distributions of the correctly predicted ligand conformations produced by our method 
(str_seqid), COACH and RaptorX-Binding. 
The distributions of the distances calculated between the coordinates of target and model 
ligands shows that, in most of the cases, our method placed ions in the models within a distance 
of only 0.5 Angstroms from the corresponding ion positions in the target. For organic ligands, the 
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difference between target and model cofactor conformation was usually below 0.8 Angstroms. 
Both for ions and for organics, the other two methods showed wider distributions, higher 
medians and higher upper quartiles. In particular, COACH had a median conformation difference 
of 0.7 Angstroms for ions and an upper quartile above 1 Angstrom for organics, while RaptorX-
Binding had the upper quartile above 1 Angstrom for ions and around 1.5 Angstroms for 
organics. 
Considering the fact that it might be difficult to identify the exact ion element from the density 
map of the protein crystal, we also assessed the three methods by ignoring the precise type of 
the target ion(s), as shown in Figure 6.10. By comparing the performances displayed in Figures 
6.6 and 6.10, we noticed that COACH gained more precision than before, while the ranking was 
not significantly affected.  
 
Figure 6.10. Precision-Recall achieved by our method, COACH and RaptorX-Binding in the ion ligand 
predictions without considering the ion atom element. 
Two examples of the accuracy of our method are shown in Figure 6.11 and Figure 6.12. In the 
first case we transferred the correct ions, two Mn2+, in the target 4BMU_1, a ribonucleotide 
reductase di-manganese(II), while COACH and RaptorX-Binding predicted only a single iron ion. 
In the second example we modelled the correct substrate, a triiodothyronine, on a thyroid 
hormone receptor alpha protein, while COACH predicted a drug-like ligand and RaptorX-Binding 
placed a different thyroid hormone. 
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Figure 6.11 Comparison of the position of ions (depicted as spheres) modelled for target 4BMU_1 (red). 
Method str_seqid (in blue) models both manganese ions, while RaptorX-Binding (in violet) and COACH (in 
green) model only a single iron ion. The binding site residues of the target and the modelled proteins are 
displayed in lighter colours. 
 
 
Figure 6.12 Comparison of the cofactors conformations (rendered in sticks) modelled for the target 
4LNW_1 (in red). Our method str_seqid models the exact target ligand (in blue), while RaptorX-Binding (in 
violet) models an analogous hormone and COACH (in green) a wrong molecule. The binding site residues 
of the target and the modelled proteins are displayed in lighter colours. 
The precision of our method in identifying a specific cofactor can be seen in Figure 6.13, where 
we correctly transferred a Nicotinamide Adenine Dinucleotide (NAD) while COACH predicted a 
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Nicotinamide Adenine Dinucleotide Phosphate (NADP) for the target 4O1M_1, an Enoyl acyl-
carrier (ENR) enzyme, which uses NAD+/NADH as cofactor. 
 
Figure 6.13 Comparison of the cofactors (rendered in sticks) modelled for the target 4O1M_1, which binds 
a NAD (in red). Our method str_seqid correctly modelled a NAD (in blue) while COACH wrongly modelled 
a NADP (in green), which has an additional phosphate group highlighted by the yellow circle. 
Discussion 
The work presented herein describes a new method for the identification and modelling of ions 
and organic cofactors within homology models, in this case created by SWISS-MODEL. As 
shown in the last CASP assessments [12, 23], the most successful methods for ligand binding 
site prediction apply a homology transfer approach. Moreover, this strategy is already 
successfully applied within the field of the protein structure prediction; therefore, we decided to 
further investigate this method and to employ it for the additional step of modelling ligands in 
their binding sites. We compared a set of models against their homologous proteins using 
different properties based on their binding site sequences and structures. We found that the best 
performances in terms of precision, recall and ligand conformation could be obtained using the 
structural sequence identity, combined to the fraction of ligand binding residues annotated in 
UniProt. In this approach, we used TM-Align to superimpose the model to the template in order 
to identify the binding site within the model; afterwards, we repeated the same step only using 
the binding site region (i.e. all the residues within 10 Angstroms from a ligand), to obtain an 
optimal local structural alignment between the model and the binding residues. The distance of 
10 Angstroms was chosen to include enough residues for the superimposition step, in case a 
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ligand was in a relatively flat site. Moreover, as TM-Align utilizes only the C-alpha atoms, the 
superimposition is not affected by the atom coordinates accuracy of the model binding side-
chains. Finally, a ligand is transferred (i.e. the atom coordinates are copied) to the model if it 
does not overlap, within a distance of 1.6 Angstrom, with any atom of the model. This constrain 
avoids creating unreliable model-ligand complexes. We decided to not apply a local docking 
procedure for the optimization of a candidate ligand conformation because it has been shown 
that the best pose in a model can be achieved by preserving the ligand native conformation [24]. 
Employing the local structural alignment allows to take into account the effects of the structural 
variability between two sites. Moreover, the evaluation of the resulting sequence identity allows 
accounting for the chemical similarity between the model and the target binding residues. In 
addition to these aspects, the use of the UniProt sequence features enhances the reliability of a 
ligand to be biologically relevant and of its corresponding templates binding residues to be the 
correct pocket site. We decided to use UniProt as a source of annotation because it contains 
information about all known protein sequences and is updated every 4 weeks; in contrast, the 
Catalytic Site Atlas database [25], which is used by other predicting methods [5, 26], only stores 
the catalytic residues of enzymes reported in literature and is updated every few years. In 
addition, the score we selected for the comparison against other methods (str_seqid) only 
depends on one parameter, that is, the minimum sequence identity for which a binding site is 
considered enough similar to the one in the model. The results of the training step indicate that 
the correct ligand for a target should be selected, in most of the cases, from the template having 
the highest binding site similarity, independently from the remaining residues of the template 
structure.  
To assess the performances of our method, we carried out a blind test on a large set of proteins 
representing a real scenario. We chose targets and models provided by the CAMEO Ligand 
Binding server. Our approach was compared with two state-of-the-art methods in the ligand 
binding predictions that place ligands in their model: COACH [11] and RaptorX-Binding 
(http://raptorx.uchicago.edu/BindingSite/). Briefly, COACH adopts a support vector machine to 
score binding sites predictions made by different methods that use sequence and structural 
information. RaptorX-Binding infers the likelihood of a pocket, and of the bound ligand, to be 
correct using the number of occurrences in the templates of the target.  
As clearly shown by the results of the precision and recall, our method was the best performing 
in the prediction of ions and had the highest recall among the three tested methods for the 
prediction of organic ligands. In this latter category, COACH showed the best precision, slightly 
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higher than our method. The higher recall obtained by our method in the organic category is due 
to the fact that we focus on biologically relevant ions and cofactors, both in the clustering and in 
the scoring step; moreover, the evaluation of the structural local sequence identity, which was 
used to select the most similar template binding site to the model, resulted in a gain in 
sensitivity. Additionally, our method is able to model ligands even in structures composed by 
multiple chains. On the other hand, although we obtained the highest recall of the three 
methods, the number of false negatives (FN) is still quite high (191 for ions and 214 for organic 
cofactors). The main reason for that is the lack of biologically relevant ions and cofactors in the 
evaluated targets. Likewise, the higher false positives (FP) number of our method with respect to 
COACH, within the organic category, is due to the extra amount of ligands that were not present 
in the target structures, but were wrongly transferred into the models. 
Despite our method showed the best performances on the testing set, there are still a few 
limitations that remain to be addressed. First of all, since we infer the target ligands by a 
homology transfer approach, we are not able to model ligands when there are no cofactors in 
any of the protein template structures. Secondly, if the model was not correctly built or the 
binding site was modelled using a template which did not have any ligand, it might happen that 
the binding site cannot accommodate the selected ligand. Finally, the templates of a target may 
not be annotated yet in UniProt and, thus, the relevance of their cofactors would remain 
uncertain. 
In the future developments of our method, we will try to address these issues using several 
strategies. For example, if there are no ligands in the templates, a pocket detection algorithm 
could be used to predict binding sites in the target, which would be later compared to a set of 
protein sites binding experimentally annotated compounds. Otherwise, a Potential of Mean 
Force approach could be used to create a set of statistics for ligand-binding site complexes, from 
which the conformation of the candidate ligand in the model could be inferred. In the case of a 
model with a bad quality binding site, one solution (alternative to ligand docking) would be to 
rebuild the model using the template from which the candidate ligand was selected by our 
scoring function. Finally, if the experimental annotation of a protein cofactor is not included in 
UniProt, it could be retrieved from additional sources, like the Kyoto Encyclopedia of Genes and 
Genomes (KEGG) COMPOUND database (http://www.kegg.jp/kegg/compound/). However, this 
type of databases includes only the ligand interacting with a protein and does not indicate the 
binding site, which should be validated by an additional source of annotations. 
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Supplementary information 
Table 1 Complete list of ligands and their frequency within the CAMEO targets composing testing set. The 
percentage column indicates the fraction of relevant ligand instances over the total number of relevant 
compounds. 
Ligand name or PDB code CAMEO category relevant not_relevant percentage 
CA I 178 55 17.72908367 
ZN I 163 28 16.23505976 
MG I 111 116 11.05577689 
Fe-S clusters O 75 28 7.470119522 
NAD(P) O 58 2 5.77689243 
FE ions I 58 2 5.77689243 
A/G-phosp. O 57 1 5.677290837 
Heme O 56 0 5.577689243 
MN ions I 32 3 3.187250996 
Biopterin O 28 0 2.788844622 
FAD O 14 0 1.394422311 
Glucose-like O 12 1 1.195219124 
U/T-phosp. O 11 0 1.09561753 
CU ions I 10 11 0.996015936 
S-AdenosylMeth. O 10 0 0.996015936 
Glutathione O 9 0 0.896414343 
Flavins O 9 0 0.896414343 
GLY O 9 0 0.896414343 
Cholesterol O 7 0 0.697211155 
polynucleotides N 7 5 0.697211155 
Molybdopterin O 6 0 0.597609562 
polypeptides P 6 9 0.597609562 
ASP O 6 0 0.597609562 
Triiodothyronine O 5 1 0.498007968 
OXY O 4 1 0.398406375 
IMD O 4 5 0.398406375 
Pyridoxal-phosp. O 4 0 0.398406375 
Coenzyme A O 3 0 0.298804781 
Sugar alcohols O 3 0 0.298804781 
ARG O 3 0 0.298804781 
LBT O 3 0 0.298804781 
22B O 3 0 0.298804781 
NI I 3 5 0.298804781 
CAA O 3 0 0.298804781 
HIS O 2 0 0.199203187 
ADE O 2 0 0.199203187 
TRP O 2 0 0.199203187 
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UPG O 2 0 0.199203187 
BET O 2 0 0.199203187 
MO ions O 2 0 0.199203187 
FOL O 2 0 0.199203187 
PAU O 2 0 0.199203187 
ICS O 2 0 0.199203187 
POP O 1 0 0.099601594 
BG6 O 1 0 0.099601594 
ILE O 1 0 0.099601594 
3PG O 1 0 0.099601594 
STR O 1 0 0.099601594 
TES O 1 0 0.099601594 
BXP O 1 0 0.099601594 
ORO O 1 0 0.099601594 
STL O 1 0 0.099601594 
LEU O 1 0 0.099601594 
CE6 O 1 0 0.099601594 
CE5 O 1 0 0.099601594 
CYS O 1 0 0.099601594 
CTR O 1 0 0.099601594 
Arabinofunarose O 1 0 0.099601594 
ASD O 1 0 0.099601594 
 
 
Table 2 PDB codes of the ―cognate‖, or biologically relevant, small molecules taken from FireDB. 
00A, 00C, 01A, 01B, 03F, 03W, 045, 06C, 13P, 149, 152, 15L, 16G, 17Z, 188, 191, 1AL, 1CA, 1CL, 1CP, 
1CU, 1GN, 1GP, 22B, 2AM, 2DG, 2FP, 2GP, 2HA, 2HP, 2MC, 2MO, 2MR, 2OB, 2OM, 35G, 3CO, 3CP, 
3GC, 3GP, 3H9, 3HC, 3ML, 3PG, 46D, 46M, 488, 4IP, 4ML, 4MO, 4PS, 5GP, 5RP, 6MO, 8OG, A, A3P, 
A4D, A5P, A8S, ABF, ABU, ACD, ACH, ACO, AD0, ADA, ADE, ADP, ADQ, ADX, AFP, AG2, AGC, AHR, 
AIR, AKG, ALA, ALE, ALL, ALO, AMP, AMZ, AND, ANE, ANR, AOR, AOS, ARA, ARB, ARG, AS1, AS4, 
ASD, ASN, ASP, ATP, B12, B1M, B1Z, B2G, B4G, BAL, BCA, BCL, BCO, BCR, BCT, BDP, BEM, BET, 
BG6, BGC, BGP, BIO, BLA, BLD, BMA, BPB, BPD, BPH, BT5, BTN, BXP, BYC, BZX, C, C0R, C1O, C2F, 
C5P, CA, CAA, CAO, CAP, CAQ, CBI, CBU, CBY, CCQ, CDL, CDN, CDP, CE5, CE6, CE8, CEG, CFM, 
CFN, CFO, CGL, CH, CHL, CIR, CIS, CL1, CL7, CLA, CLF, CLL, CLP, CLR, CM1, CM2, CMO, CMP, 
CN1, CNB, CNC, CNF, CO2, CO6, CO8, COA, COB, COD, COH, COJ, COO, COS, COW, COZ, CP2, 
CP3, CRN, CSE, CTP, CTR, CU, CU1, CU3, CUA, CUB, CUK, CUM, CUN, CUO, CXR, CYC, CYS, CYT, 
CZL, D2V, DA, DA2, DAC, DAK, DAL, DC, DCC, DEF, DFL, DFV, DG, DGL, DHB, DHC, DHE, DHT, DI, 
DLZ, DN, DNO, DOC, DPM, DPN, DQR, DT, DTP, DU, DXC, E2P, EA2, EB4, ECH, EDC, EFE, EIC, 
EMU, F3S, F42, F43, F4S, F6P, F6R, FA, FAD, FAQ, FBP, FCA, FCB, FCI, FCO, FDA, FDC, FDP, FE, 
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FE2, FEL, FEO, FER, FES, FMN, FOC, FOL, FPC, FPP, FRE, FRU, FS1, FS2, FS3, FS4, FSF, FSO, 
FUB, FUC, FUD, FUM, G16, G1P, G1R, G2Q, G2R, G3H, G3P, G4P, G6P, G6Q, GA3, GA4, GAE, GAL, 
GAR, GCD, GCS, GCU, GCV, GDC, GDD, GDP, GDR, GDU, GLA, GLC, GLN, GLO, GLP, GLU, GLV, 
GLY, GMP, GNP, GP5, GRA, GRG, GSH, GTP, GTR, GTS, GTT, GUD, GUN, GZL, H35, H4B, H4M, 
HAM, HAS, HBI, HC4, HCB, HCC, HCN, HCO, HDC, HDD, HDE, HEA, HEB, HEC, HEG, HEM, HEQ, 
HGS, HIF, HIS, HMG, HPA, HSC, HSE, HSM, HSO, HTL, HXC, I0P, I2A, I2P, I3P, I3S, I4P, I5P, I6P, IAC, 
ICA, ICS, ICT, IDR, IGP, IHP, ILE, IMD, IMI, IMP, IND, INS, IP1, IP2, IPL, IPR, ISC, ISD, ITM, ITT, JB2, 
JB3, JN3, KDG, KDP, KOJ, LAI, LAN, LAT, LBT, LBV, LDP, LEU, LFC, LFR, LGU, LMG, LNL, LNR, LPA, 
LUM, LYS, M1P, M2P, M43, M6P, MAB, MAN, MAX, MC4, MCA, MCN, MDO, MET, MEV, MG, MH2, 
ML1, MLC, MLR, MM4, MMP, MN, MN3, MNH, MO, MOM, MOO, MOS, MOW, MP1, MQ7, MQ8, MQ9, 
MRR, MRS, MSS, MTA, MTL, MTQ, MTT, MTV, MXY, MXZ, MYA, MYR, NAD, NAI, NAP, NBC, NCA, 
NDP, NFC, NFE, NFO, NFR, NFS, NFV, NG1, NGA, NI, NIO, NLG, NMN, NO, NOS, NTM, NTN, OAA, 
OC1, OC2, OC3, OC4, OC5, OC6, OC7, OC8, OCR, OFE, OMO, OMP, OPC, ORN, ORO, OXK, OXS, 
OXY, P5P, P7I, PAB, PAU, PC, PCA, PCD, PCG, PDP, PEB, PEE, PEP, PG2, PGP, PHE, PIE, PLP, 
PNS, POP, POR, PP9, PPR, PQN, PQQ, PRO, PTE, PTR, PTT, PUB, PVL, PVN, PXL, PXM, PXP, PYG, 
PYH, PYM, PYQ, PYR, QDK, QUE, R1P, R5P, RAF, RB5, RBF, RCC, REA, RED, RET, RG1, RIB, RIP, 
RNS, RNT, ROA, ROM, RTL, RUB, RUT, S0N, S3P, S6P, SAC, SAH, SAM, SAR, SCA, SCG, SER, SF3, 
SF4, SFT, SMO, SOR, SPF, SPH, SPN, SPO, SRM, SRO, ST9, STE, STL, STR, SUG, SUO, SUP, T1G, 
T3, T3P, T6P, TC6, TCH, TDP, TDR, TES, TGC, TH3, THG, THM, THP, THR, TMP, TP7, TPO, TPP, 
TPQ, TPS, TRA, TRP, TRQ, TS5, TSS, TTP, TTQ, TYD, TYR, U, U10, U5P, UAG, UD1, UD2, UDP, 
UMA, UMP, UP2, UP3, UPG, UQ, UQ1, UQ2, UQ7, UQ8, URA, URC, URI, UTP, VAL, VBN, VD3, VDX, 
VDY, VER, VIB, VIT, VIV, VK3, WCC, XAN, XCC, XMP, XX2, XX3, XXP, XYL, XYP, XYQ, XYS, ZEA, 
ZIR, ZN, ZNH. 
 
Table 3 PDB codes of the ―ambiguous‖ ligands adapted from FireDB. 
1BO, 3GR, ABA, ADN, AG, AME, APR, ASC, ASE, BES, BR, CAC, CD, CFF, CIT, CL, CLM, CO, CO3, 
CYN, DCE, DSN, FLC, FUL, IOD, K, LAC, MAL, MLA, MLI, MLT, NA, NH2, NH4, NO3, OLA, OXL, PAM, 
PLM, PO4, RAM, SCN, SEP, SIA, SIN, SMX, SO4, SPD, SPM, SUC, TLA, TRE, URE, XD2, V, W, WO4, 
WO5, VO4. 
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7. Moment invariants for binding sites description 
Introduction 
The shape of any distribution can be mathematically described by a set of quantitative measures 
called ―moments‖. The moments which are most commonly used to characterize a given 
distribution are mean, variance, skewness and kurtosis. Additional types of moments, those 
beyond the 4th-order, involve non-linear combinations of the data and are useful to describe or 
estimate further shape parameters; however, since these moments are harder to estimate and 
subtle to interpret, they are in general less used.  
Moments can be further distinguished in ―central‖, when they are computed in terms of the 
deviations from the mean, and ―ordinary‖, in case the reference point is the zero; the former type 
of moments is usually preferred, as it is only dependent on the spread and shape of the 
distribution, rather than on its location.  
The first moment is the mean, which is the average value of a distribution. The second moment 
is the variance, which is a non-negative quantity defined as the square mean of the distances of 
the values from their mean and represents the spread of the data. The third moment is the 
skewness, which measures how much the distribution is asymmetrical; it equals zero if the 
distribution is perfectly symmetrical. The fourth moment is the kurtosis, which describes whether 
the distribution is peaked and narrow or flat and wide, with respect to a Gaussian distribution 
having the same variance. Any central moment can be normalized and is independent on the 
scale if divided by the variance elevated to the order of the moment.  
The ―moment invariants‖ are functions of the moments such that they do not change their value 
when the distribution is transformed. Moment invariants can be used to describe the shape of a 
three-dimensional distribution of points, independently from their position and orientation. 
Although they are mostly employed in image analysis, these shape descriptors have been also 
used in the structural biology field as feature vectors to efficiently represent and compare 
protein-protein interfaces [1].  
Our aim is to adopt moment invariants as protein pocket descriptors in the context of the de 
novo ion binding site prediction. 
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Methods 
We collected from the PDB database [2] a set of about 13000 X-ray protein structures that had a 
minimum resolution of 2.5 Angstroms, a R-value ≤ 0.25 and that were bound to divalent cations 
(Calcium, Copper, Iron, Magnesium, Manganese, Zinc). Next, we only kept those structures 
whose bound ion was annotated in UniProt/SwissProt [3] in order to create a set of proteins 
which had experimental evidence of the interaction with a cation. This filtering step produced 
1675  proteins, in which 325 were bound to Calcium, 65 to Copper, 82 to Iron, 119 to 
Manganese, 274 to Magnesium and 435 to Zinc. Ignoring the ions that were bound to less than 
3 protein residues resulted in a total number of 1187 binding sites. 
In each binding site, we divided the residues in clusters according to the type of atom that was in 
contact with the ion. For simplicity, every atom was mathematically represented by a Gaussian 
density function in the three dimensions. For each cluster, the first three moment invariants 
(mean, variance, skewness) were calculated using three different approaches: (i) considering 
only the atoms in direct contact with the ion, (ii) using all the atoms belonging to the whole 
residues and (iii) utilizing only the C-alpha carbons. Accordingly, each cluster of residues was 
represented by 9 values, corresponding to the sum of the residue moments (1st, 2nd and 3rd) 
along each axis (x, y and z).  
In particular, the first moment was calculated as: 
𝜇1,𝑋 =   𝑎𝑘 − 𝑥 
𝑘
 
𝜇1,𝑌 =   𝑎𝑘 − 𝑥 
𝑘
 
𝜇1,𝑍 =   𝑎𝑘 − 𝑥 
𝑘
 
the second moment was calculated as: 
𝜇2,𝑋 =    𝑎𝑘 − 𝑥 
2 + 𝜎2 
𝑘
 
𝜇2,𝑌 =    𝑎𝑘 − 𝑥 
2 + 𝜎2 
𝑘
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𝜇2,𝑍 =    𝑎𝑘 − 𝑥 
2 + 𝜎2 
𝑘
 
and the third moment was calculated as: 
𝜇3,𝑋 =    𝑎𝑘 − 𝑥 
3 + 3 𝑎𝑘 − 𝑥 𝜎
2 
𝑘
 
𝜇3,𝑌 =    𝑎𝑘 − 𝑥 
3 + 3 𝑎𝑘 − 𝑥 𝜎
2 
𝑘
 
𝜇3,𝑍 =    𝑎𝑘 − 𝑥 
3 + 3 𝑎𝑘 − 𝑥 𝜎
2 
𝑘
 
where 𝑎 indicates the position of the 𝑘th atom and 𝑥 the centre of mass of the residue cluster, 
which is used as origin, or central point, for the shape density of the residue cluster. These 
moments were subsequently normalized and transformed in order to make them ―invariant‖ to 
their position and orientation in the three-dimensional space, as described in [1]. The moment 
invariants were finally grouped in a feature vector to represent the binding site; in this way, the 
binding sites could be compared to each other by their distance in the Euclidean space. To verify 
that the moment invariants could be sufficiently accurate in describing the binding sites of our 
dataset and, more importantly, in classifying them according to the bound ion, we used a two-
step procedure: first, we employed the R implementation of the Partition Around Medoid (PAM) 
algorithm [4] to cluster the moment invariants; secondly, we measured the level of correct 
clusters partitioning through the ―silhouette‖, a graphical aid for the interpretation and validation 
of cluster analysis [5]. The PAM method, which belongs to the k-means family of algorithms, 
divides a dataset in an a priori defined number of groups and clusters the points in the dataset 
by minimizing the sum of their pairwise dissimilarities. This approach is more robust against 
outliers and noise with respect to the other k-means methods, which employ the sum of squared 
Euclidean distances to create the clusters. In our case, the PAM method provides a useful way 
to group the moment invariants, particularly because we already know the expected number of 
clusters, which corresponds to the number of different ions in the dataset. The main advantage 
of the silhouette is to provide a graphical evaluation of the clustering validity, that is, to estimate 
whether the points in a dataset were correctly clustered in the appropriate group. An average 
value close to 1 indicates that the number of clusters accurately reproduced the classification of 
the underling members, while an average value close to -1 means that most of the data points 
(in our case, the binding sites) were assigned to the wrong cluster. 
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Results and discussion 
The aim of this project was to investigate whether the moment invariants could be used to 
efficiently describe the geometry of ion binding sites, and therefore, for the de novo identification 
of ion binding sites in a protein model. To verify the ability of moment invariants in representing 
binding sites, we clustered them and evaluated whether the resulting number of groups was 
coherent with the expected number of clusters, corresponding to the 6 different types of ions 
which were present in our dataset. Accordingly, the maximum average silhouette value should 
have been measured when dividing the moment invariants in exactly 6 groups. We clustered the 
moment invariants with a variable number of groups, ranging from 2 to 10, and for each round 
we calculated the silhouette. Figure 7.1 shows the silhouettes measured with 2 clusters, while 
Figure 7.2 illustrates the silhouettes obtained using 6 clusters. In both cases all the atoms of the 
binding residues were used to calculate the moment invariants.  
 
Figure 7.1 Silhouette plot of the moment invariants clustered in 2 groups. On the top left corner, ―n‖ 
indicates the number of binding sites; at the right side of each silhouette, it is indicated the number of 
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points in the cluster and the silhouette width; at the bottom of the figure, it is shown the average silhouette 
width of the 2 clusters.  
 
Figure 7.2 Silhouette plot of the moment invariants clustered in 6 groups. On the top left corner, ―n‖ 
indicates the number of binding sites; at the right side of each silhouette, it is indicated the number of 
points in the cluster and the silhouette width; at the bottom of the figure, it is shown the average silhouette 
width of the 6 clusters.  
The maximum average silhouette was 0.63 and was obtained by setting to 2 the number of 
clusters; using different numbers of clusters, the maximum average silhouette was always lower 
than this value. For example, as shown in Figure 7.2, using 6 clusters produced a value of 0.54. 
The highest average silhouette was found using 2 clusters also when we calculated the moment 
invariants by selecting only the atoms in contact with the ions, as well as when we selected only 
the C-alpha carbons of the binding residues. 
Since the expected number of clusters with the best silhouette was 6 instead of 2 (as shown by 
the silhouette), these results suggest that the moment invariants, even when calculated 
separately for each type of residue in contact with the ion, are not a suitable method to 
accurately describe in detail the ion binding sites. We performed the same analysis for the 
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comparison of the different coordination geometries created by each ion. The silhouette values 
of the clustered sites followed the same behaviour as in the comparison of all ion sites, meaning 
that the binding sites of each ion were optimally clustered in two groups, independently of the 
actual number of coordination geometries. These outcomes can be better understood by taking 
into account the fact that the distributions of the ionic distances and of the coordination numbers 
– i.e. the number of atoms making a bond with the ion – are very similar among the ions found in 
proteins [6]. Moreover, protein ion binding sites can be arranged in a distorted shape that makes 
its classification into a well defined geometry more difficult. Hence, these features are not 
enough different from one ion binding site to another and, therefore, moment invariants cannot 
be efficiently used to distinguish ion binding sites. 
However, organic ligand binding sites are more diverse in shape with respect to ion binding 
sites; therefore, an interesting development for future studies would be to investigate whether 
the moment invariants could be successfully applied for their identification and classification. 
References 
1. Sommer, I., et al., Moment invariants as shape recognition technique for comparing 
protein binding sites. Bioinformatics, 2007. 23(23): p. 3139-46. 
2. Berman, H.M., et al., The Protein Data Bank. Nucleic Acids Res, 2000. 28(1): p. 235-42. 
3. The UniProt Consortium, Activities at the Universal Protein Resource (UniProt). Nucleic 
Acids Res, 2014. 42(Database issue): p. D191-8. 
4. R Development Core Team, R: A language and environment for statistical computing. 
2011, R Foundation for Statistical Computing: Vienna, Austria. 
5. Rousseeuw, P.J., Silhouettes: A graphical aid to the interpretation and validation of 
cluster analysis. J Comp Applied Math, 1987. 20(11): p. 53-65. 
6. Zheng, H., et al., Data mining of metal ion environments present in protein structures. J 
Inorg Biochem, 2008. 102(9): p. 1765-76. 
 
 
8. Conclusion 
In this thesis we presented the assessment of the current methods for the prediction of ligand 
binding sites in protein models, during the last two rounds of the CASP experiment. In addition, 
we described the development of a pipeline for modelling small molecules in homology models 
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and the prediction of their binding sites. Finally, we tested a novel approach for the description 
of ion binding sites. 
In the recent CASP9 and CASP10 editions, the evaluation of the ligand binding site predictors 
for proteins without a known structure indicated the strengths and weakness of the current 
state-of-the-art prediction methods. The results showed that the most successful participants 
employed approaches based on the transfer of binding residue annotations from the target 
homologous proteins to the model. The main limitation of these methods resides in the variable 
availability of binding information, either retrieved from the protein sequences or from the 
structures with bound ligands. Both in CASP9 and CASP10, the assessment method showed 
some limitations. The first was the low number of targets bound to relevant ligands; the second 
consisted in the binary classification of the target residues in either ―binding‖ or ―non-binding‖, 
without any measure of confidence; the third limitation was the absence of any information 
regarding the type of bound ligand. The CAMEO server was developed to address these 
weaknesses, in order to provide a fast and accurate assessment of the current methods and to 
guide the development of the binding site prediction field towards new directions. 
We implemented a baseline homology transfer predictor in SWISS-MODEL to provide a 
reference performing method of ligand binding site prediction for comparison with more 
advanced methods within CAMEO. The method consisted in the transfer of the template ligands 
into the model and in the identification of the conserved residues that were in contact with small 
molecules. Despite being a baseline approach, our method achieved a very good performance, 
especially in the ion category. However, since these good results were obtained only for a 
limited number of targets, this prompted us to develop an improved version for the new SWISS-
MODEL server, based on a multi-template approach and focussed on the modelling of 
biologically relevant ligands. We compared, in a blind test, our new method with the two best 
public servers that provided models with bound ligands in the CAMEO Ligand Binding section. 
We showed that our performances, in the ion and organic categories, were overall more 
accurate with respect to the other two servers, both in terms of ligand type and of conformation 
within the model. These results indicate that the identification of biologically relevant ligands in 
templates plays an important role in the prediction of the correct ligand for a given target and, 
moreover, suggest that the ligand conformation found in the template is enough precise to not 
require an additional refinement step. Furthermore, these results indicate that while the binding 
prediction field is mature enough to produce accurate results, new methods should focus on the 
precise modelling of the ligand itself and of its binding residues. A further improvement in the 
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direction of ligand and binding site modelling could be the selection of the template based on 
the best candidate ligands for the target. This approach should allow building models with better 
quality in the binding site region and a more precise ligand annotation than current homology 
methods, although the quality in other parts of the models may become worse. This 
consideration would promote the development of modelling pipelines that employ a template for 
the binding site and another for the rest of the target. On the other hand, the limitation imposed 
by available ligands in protein structures suggested that the development of de novo ligand 
modelling methods might represent a valuable alternative. 
Finally, we tested the moment invariants as a new approach for an efficient description and 
comparison of ligand binding sites in a de novo predictor; however, we concluded that this 
representation of ion binding sites was not a suitable option, mostly because it was not enough 
accurate in discriminating different binding sites. In the future steps of the analysis, it will be 
interesting to verify whether these descriptors could be successfully used to represent and 
identify the binding sites of organic ligands. 
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